Global Advisory Panel on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies

Tools

GAP Annual Report 2014
GAPANNUALREPORT2014Global Advisory Panel onCorporate Governance andRisk Management of BloodServices in Red Cross andRed Crescent SocietiesGood Governance, safe blood.aGAPANNUAL REPORT 2014GAPANNUAL REPORT 2014CONTENTS1. GAPs Role12. GAP Association Governance23. Strategic Plan54. Global Mapping65. Self-assessment96. Management of Risk107. Projects118. Priority Countries169. Finance19GAPANNUAL REPORT 20141.GAPS ROLEWe advocate and support the establishment of safe and sustainable bloodsystems, promote the adoption of best practice, and facilitate resourcemobilization and knowledge transfer between blood services.The purpose of GAP is to provide advice to National Red Cross and Red Crescent Societies, and their affiliatedblood services, in matters concerning corporate governance and risk management in the field of National Societyblood programmes, as well as the International Federation of Red Cross and Red Crescent Societies (IFRC)Secretariat and other relevant IFRC bodies.GAPANNUAL REPORT 20142.GAP ASSOCIATION GOVERNANCEIn 2014, Prof Philippe Vandekerckhove, Chief Executive Officer of the BelgianRed Cross Blood Service (Flanders) held the position of GAP President.GAP is comprised of an Executive Board, the members of which play a vital role in governance and decision makingfor the organisations activities. An IFRC permanent observer holds a position on the GAP Executive Board to ensurethe flow of information and coordination with the IFRC. Regular communication and constructive ties between GAPand the IFRC Secretariat ensures the coordination of work programs and supports links particularly with respectto voluntary non-remunerated blood donation (VNRBD).The GAP Zonal Coordinators liaise closely with their IFRC zone office(s) and look for opportunities to collaborateon activities in the critical area of corporate governance and risk management for National Societies involvedwith blood programmes.GAP Executive BoardAims: To provide technical advice in terms of corporate governance and risk management to National Societyblood programmes; To promote knowledge sharing, networking and partnership among and between Red Cross and Red Crescentblood services and external partners; To develop tools and guidelines as appropriate within the area of National Society blood programme delivery; To coordinate Red Cross/Red Crescent assistance to National Red Cross and Red Crescent blood servicesin post-emergency situations.1.2.1. Prof Philippe VandekerckhovePresident2. Dr Wolfgang MayrVice President3. Dr Rudolf SchwabePermanent Board member4. Ms Jennifer WilliamsBoard member3.14.5. Dr Stefan Seebacher/ Dr Gabriel PictetIFRC Permanent Observer (Absent)2GAPANNUAL REPORT 2014GAPANNUAL REPORT 2014GAP Association StructureGAP Finland representativeOne of GAPs founding members; Dr Tom Krusius from the Finnish Blood Service retired from the Blood Servicein 2014 and consequently vacated his position as GAP Zonal Coordinator for Europe and Central Asia. Dr Krusiushas been a very active GAP member, with particular contribution at the time of the 2004 Boxing Day tsunami,where he led the coordination of responses in affected countries.GAP Executive BoardDr Martti Syrjl, Chief Executive Officer, Finnish Red Cross Blood Service, is now providing Finlandsmember representation on GAP.Appointment of Europe & Central Asia Zonal CoordinatorGAP SecretariatFinancial Auditor Dr Elizabeth VinelliAustralian Red Cross Blood ServiceInternational Federation of Red Crossand Red Crescent SocietiesGAP Members, Zonal Coordinators and Permanent ObserversAfrica[ZC Position Vacant]AmericasLatin America& the CaribbeanUSADr Richard Benjamin(ZC)HondurasDr Elizabeth Vinelli (ZC)Asia & PacificChina (Hong Kong)Dr Che Kit Lin (ZC)JapanDr Kenji Tadokoro (ZC)AustraliaMs Jennifer WilliamsThailandDr Soisaang PhikulsodEurope &Central AsiaMiddle East &Northern AfricaFinlandDr Tom Krusius (ZC)Dr Martti SyrjlIsraelProf Eilat ShinarAustriaDr Wolfgang Mayr (ZC)Belgium (Flanders)Prof PhilippeVandekerckhoveGermanyDr Erhard SeifriedSwitzerlandDr Rudolf Schwabe[ZC Position Vacant]Dr Wolfgang Mayr from the Austrian Red Cross Blood Service was nominated unchallenged to the positionof GAP Zonal Coordinator for the Europe and Central Asia region in November 2014. The position wasconfirmed and Dr Mayr commenced the role in January 2015.IFRCDr Stefan SeebacherDr Gabriel Pictet(Permanent Observer)Dr Guenther Wittauer(Senior VNRBD Officer)Permanent Observer and VNRBD OfficerIn October 2014 Dr Stefan Seebacher retired fromhis position as Head of Health Department, IFRC.Dr Gabriel Pictet is currently acting in this positionand is representing the IFRC as a PermanentObserver on the GAP Executive Board.Guenther Wittauer retired from his position as SeniorVoluntary Non-Remunerated Blood Donation Officer(Health Department, IFRC) in June 2014. The positionremained vacant for the remainder of 2014.Blood Policy ReviewA review of the IFRC Blood Policy commenced in late 2014. A number of suggested changes were proposedand reviewed by the Secretariat and members. The final version of the Blood Policy will be approved by GAPand the IFRC in 2015.Memorandum of UnderstandingThe Memorandum of Understanding (MOU) between the IFRC and GAP was accepted signed by both partiesat the GAP Executive Board meeting in Madrid, April 2014. This MOU sets out the modalities of the partnershipbetween the two organisations including, but not limited to:The IFRC role in GAP;The reporting obligations including Major Material Risk;The engagement with the National Society through a Self-assessment process;Funding;Priority country support andThe coordination of blood programmes in disaster situations.34GAPANNUAL REPORT 2014GAPANNUAL REPORT 20143.4.GAPs initial strategic plan was developed in 2007 for the period 2009-2012. The plan includeda vision and mission statement, primary objectives and key outputs. During 2014, these werereviewed with feedback from members on GAPs strengths, weaknesses and opportunities.The new GAP Strategic Plan for 2014-2019 was finalised at the 2014 AGM with updatedvision and mission, key objectives and performance indicators.In 2013 and 2014, GAP conducted global mapping to determine the level of involvement thatRed Cross and Red Crescent National Societies have in the provision of their nations bloodprogramme. A survey was created by GAP and distributed to National Societies in the regionsof Africa, the Americas, Latin America & the Caribbean, Asia Pacific, Europe & Central Asia andMiddle East & Northern Africa. The survey requested the National Society to indicate whetherthey were involved in a blood programme at Level A, B or C or had no involvement.STRATEGIC PLANVISION:GLOBAL MAPPINGAll Red Cross/Red Crescent blood programmes will be safe, well governed and self-sustainable, based on theprinciple of voluntary non-remunerated blood donation for the benefit of patients and to safeguard blood donors.MISSION:A. Full Blood Service ProvisionGAP will support Red Cross/Red Crescent blood services in risk management and corporate governanceof blood programmes and promote good practices and knowledge exchange.OBJECTIVES:1.GAP to be recognized as a global network of experts in risk management and corporate governanceof blood programmes.2.Enable all Red Cross/Red Crescent blood services to undertake the GAP Self-assessment and demonstrateprogress towards achieving compliance with minimum standards and fundamental GAP requirements.3.Relationships, networks and collaborations will be developed which improve GAPs reach and effectivenessand to help execute GAPs programme of work.4.Service delivery will be enhanced through the provision of practical help to Red Cross/Red Crescent BloodServices to improve safety, sufficiency and good governance.5.Extend involvement of GAP membership to improve the reach of expertise available.6.IFRC will be supported by GAP activities in the goal of achieving 100% voluntary non-remunerated blooddonation and implementation of the IFRC Blood Policy.B. Systematic Blood Donor RecruitmentC. Advocacy for VNRBDPromotional campaignsEducation and awarenessInvolvement in WBDDDonor recruitmentPromotional campaignsEducation and awarenessInvolvement in WBDDGovernanceAdvocacy for appropriate useProduct distributionLaboratory testingComponent preparationCollection services/donor careDonor recruitmentPromotional campaignsEducation and awarenessInvolvement in WBDDOf the 186 surveys distributed in the 2 year period, only 71 (38%)National Societies responded to the global mapping exercise, a notablylow response rate. A summary of the results is displayed on thefollowing pages, these also include information gathered throughthe Self-assessment process and through GAPs member network.GAP plans to perform an extended global mapping exercise in 2015-2016 to obtain accurate information on all National Society Blood Services.This is critical for GAP and the IFRC to plan for future support activities andto conduct Self-assessment processes at regional and global levels.56GAPANNUAL REPORT 2014GAPANNUAL REPORT 20142013-2014 Global Mapping ResultsNo.National SocietyLevel of InvolvementNo.National SocietyLevel of InvolvementAsia & PacificAmericas, Latin America & the Caribbean1American Red CrossA37Pakistan Red Cross SocietyA2Colombian Red Cross SocietyA38Philippine Red CrossA3Ecuadorian Red CrossA39The Thai Red Cross SocietyA4Honduran Red CrossA5Suriname Red CrossA40Vietnam Red Cross SocietyB41Micronesia Red CrossB6Dominica Red Cross SocietyB42The Sri Lanka Red Cross SocietyB7Saint Lucia Red CrossB43Afghan Red Crescent SocietyC8Bolivian Red CrossC44New Zealand Red CrossNil9The Canadian Red Cross SocietyNil10Costa Rican Red CrossNil45Austrian Red Cross SocietyAMiddle East & Northern Africa (MENA)Europe & Central Asia46Spanish Red Cross SocietyA11Egyptian Red Crescent SocietyA47Belgian Red CrossA12Magen David Adom in IsraelA48Finnish Red CrossA13Lebanese Red CrossA49German Red CrossA14Red Crescent Society of the Islamic Republic of IranA50Luxembourg Red CrossA15Iraqi Red Crescent SocietyB16Algerian Red CrescentC51Swiss Red CrossA17The Palestine Red Crescent SocietyC52Andorran Red CrossB18Moroccan Red CrescentNil53Bulgarian Red CrossB19Qatar Red Crescent SocietyNil54Croatian Red CrossB55Cyprus Red Cross SocietyB56Hungarian Red CrossB57Red Cross of MontenegroB58Norwegian Red CrossB59The Red Cross of SerbiaB60Slovenian Red CrossB61Ukrainian Red Cross SocietyB62Albanian Red CrossC63Estonia Red CrossC64Malta Red Cross SocietyC65Red Cross Society of the Republic of MoldovaC66Romanian Red CrossC67Red Crescent Society of TajikistanC68Armenian Red Cross SocietyNil69Belarus Red CrossNil70British Red CrossNil71Danish Red CrossNil72Icelandic Red CrossNil73Irish Red Cross SocietyNil74Lithuanian Red Cross SocietyNilAfrica20Red Cross of BeninB21Togolese Red CrossB22Uganda Red Cross SocietyB23Central African Red Cross SocietyB24Red Cross Society of EritreaC25Ethiopian Red Cross SocietyC26Liberian Red Cross SocietyC27Malagasy Red Cross SocietyC28The Sudanese Red CrescentCAsia & Pacific29Australian Red CrossA30Bangladesh Red Crescent SocietA31Indian Red Cross SocietyA32Indonesian Red Cross SocietyA33Japanese Red Cross SocietyA34The Republic of Korea National Red CrossA35Laos Red CrossA36Nepal Red Cross SocietyA78GAPANNUAL REPORT 2014GAPANNUAL REPORT 20145.6.GAPs principal tool when working with National Society Blood Services is the Self-assessmentquestionnaire. The Self-assessment assists National Societies to ensure that appropriate stepsare taken to support the long term stability and sustainability of their blood service withoutexposing the Society to any unnecessary risks. It enables National Society blood programmesto measure their progress against key issues which have been identified as fundamental aspectsof corporate governance and risk management for Red Cross/Red Crescent blood programmes.GAP has a responsibility under the IFRC Blood Policy to inform both the IFRC Secretariat andconcerned National Societies of Major Material Risks (MMR) for the IFRC discovered throughthe GAP Self-assessment programme and any other GAP work.SELF-ASSESSMENTMANAGEMENT OF RISKAsia-PacificThe Self-assessment process was conducted throughout theAsia Pacific region in late 2013, with participation from 13 LevelA National Society Blood Services. Following the analysis anddistribution of the individual and regional feedback reports,a regional meeting was held on 20th September, 2014 inKathmandu, Nepal. Participants from the Blood Servicesof The Philippines, Nepal, Indonesia, Thailand, Hong Kong,Japan, Australia and the GAP Secretariat attended. Participantsprovided country updates and reviewed and discussed the regionalSelf-assessment results including potential strategies to addresscommon regional risk management challenges.Self-assessment TranslationsThe revised Self-assessmentquestionnaire has been fully translatedinto Spanish and Arabic languages.Both translations are available on theGAP and IFRC Fednet websites.Middle East and Northern Africa (MENA)In September 2014 the Self-assessment questionnaire was distributed to the National Society Blood Servicesin the MENA zone who had confirmed in the 2014 global mapping survey that they are involved in a Level A bloodprogram. Individual country feedback reports were issued to the respondents, identifying key areas of potential riskfor the blood service together with suggested strategies to address these. As there were insufficient respondentsto retain the anonymity of the supplied information, a de-identified regional report was not issued and a regionalmeeting was not held.IndiaFollow-up activity with regards to Indias 2013 Self-assessment response (Asia Pacific region) identified that thereare 166 independently operating Red Cross Blood Service centres in the country, and that the Self-assessmentdata reviewed by GAP in 2013 is not indicative of all centres. As it is not feasible for GAP to distribute the surveyto all 166 centres with its current resources, GAP will initially distribute the Self-assessment to a sub-set of thelargest Red Cross Blood Services centres. The Self-assessment questionnaire was sent out in November 2014with the assistance of the Indian Red Cross Society.Major Material Risk, is defined by GAP as being: A circumstance in which an individual National Society or BloodService knowingly endangers a high number of donors and/or recipients or acts in contravention to the principlesof the Federation, thereby exposing the IFRC or sister National Society to potential reputational damage. An MMRbehaviour is defined by GAP as being any conduct by a National Society or Blood Service which has the potentialto cause an MMR.Major Material Risk FrameworkThe IFRC Secretariat and GAP members developed a comprehensive set of operating rules and a frameworkfor risk reporting to guide GAP in its activities. The Major Material Risk Advisory Framework was finalised in late2013 by GAP and the IFRC as the agreed methodology to identify, report and manage MMR in National SocietyBlood Services.The Self-assessment process conducted in the Asia Pacific and Middle East & Northern Africa regions in2013-2014 provided the first opportunity for use of the new MMR framework. In accordance with the framework,GAP was required to follow-up with a number of National Society Blood Services in response to the answers providedto particular questions in the Self-assessment which may indicate a potential MMR situation exists. Individual countryfollow-up was progressed by the GAP Secretariat in conjunction with the Asia Pacific Zone Coordinators, and inaccordance with the agreed MMR framework.Following the first in-practice use of the framework for the follow-up of Self-assessment results in the AsiaPacific region in 2013/2014, the framework was reviewed by the GAP Executive Board. The review highlightedthat application of the agreed MMR framework to the Self-assessment responses received from the region wouldrequire GAP to follow up with many National Society Blood Services that may not have a true MMR. It was agreedthat the MMR process flowchart contained within the IFRC Major Material Risk Advisory Framework would berevised to further clarify the process.Self-assessment QuestionnaireThe Self-assessment questionnaire was also reviewed in 2014 to include additional questions (see table below)to ensure that it does not trigger an unspecified MMR, but will trigger a demonstrable and specific incident whichrequires the attention of the IFRC. By specifically requesting further information from the National Society BloodService within the questionnaire, the need for unnecessary follow-up will be circumvented wherea true MMR does not exist. A summary of these questions is provided below.An Indian sub-regional meeting will be held in 2015 to discuss the results. The GAP Executive Board willdetermine an appropriate strategy for further action, if required, once further clarity on the scale and scopeof the Red Cross Blood Service in India is known. This may include the further distribution of theSelf-assessment to additional centres.Additional Self-assessment questionsExplanation1.2.1If YES or Partially:Have these policies been implemented?What is the level of VNRBD in your country?Are there steps in place to increase VNRBD?1.2.2If NO:What is the level of VNRBD in your country?Are there steps in place to increase VNRBD?1.4.1If not, Why?Are plans in place to change this?These questions request additional information if the blood service indicates that they do not havea long-term sufficient and sustainable source of revenue.1.5Does the Blood Service have sufficient of the following resources to meet regulatory requirements(facilities, supplies, equipment, trained staff/volunteers)?If the blood service selects No, slight shortage or No, significant shortage a prompt for furtherinformation has been added and a caution that a negative response may indicate a potential MMR.4.1If NO, which agency provides support for these recipientsThis question asks for further information if the blood service states that they (or the health department)do not have a mechanism for providing support to recipients of infected blood.Are you participating in any bilateral support programmes for your blood service?Part BAre you receiving any funds from other sources to support bilateral arrangements?These questions prompt the blood service to provide additional information in regards to a national policyof securing supply of safe blood through voluntary non-remunerated blood donation (VNRBD).These questions request further information from the blood service regarding any existingsupport arrangements.910GAPANNUAL REPORT 2014GAPANNUAL REPORT 20147.PROJECTSAfrica Zone (IFRC Funding 2013 2014)GAP sought to increase its level of support in the Africa and MENA (Middle East & Northern Africa) Zonethrough the completion of the Self-assessment process and efforts to attract and train a Zone Coordinator(ZC) for the region.The responses from the Africa Zone to the GAP global mapping survey in 2014 did not identify a NationalSociety with current involvement in blood activity at Level A or B. Two level C National Societies were identified Madagascar and Sudan. This indicated that a request for a representative to consider the role of GAP ZoneCoordinator (ZC) in the Africa region was not warranted at this time given the absence of Level A and B activity.GAP Priority Country (Nepal) Joint IFRC and Hong Kong Red Cross Funding (2013-2014)A collaborative initiative between the Hong Kong Red Cross Blood Transfusion Service (HKRC BTS), Nepal RedCross Society National Blood Transfusion Service (NRCS NBTS) and GAP, this project aimed to build capacityin the Nepal BTS through provision of support in three key areas:1.Procurement and installation of critical equipment;2.Providing technical support by developing a risk management frameworkand providing training on donor care and counselling;3.Improving national coordination of the blood program by holding a developmentforum with key stakeholders.Following an extensive procurement process by the project steering committee, the equipment was purchasedin July 2014 from Insignia International (New Delhi) and was delivered to the Nepal Red Cross Society CentralBlood Transfusion Service on 25th August 2014. This supplier was chosen due to their proximity to Nepal(reduced transport costs), competitive pricing and excellent service and communication. Plaques were placedon the equipment acknowledging the funding from the Hong Kong Red Cross.The in country support component of the project was undertaken from August 25th 29th 2014. The teamincluded GAP Asia Pacific Zone Coordinator and HKRC BTS technical expert Dr Che Kit Lin, Ms Michelle Wsolakand Ms Emily Tonks from the GAP Secretariat and Australian Red Cross Blood Service risk management expertsMr Christopher Wheatley and Mr Mathew Manning.The week long programme included training workshops, a high level development forum and a number of meetingswith key stakeholders in Nepal including Dr Manita Rajkarnikar (Director of the NRCS NBTS), the Secretary Generalof the Nepal Red Cross Society, representatives of the governments National Public Health Laboratories, WHO andthe US Embassy. The meetings included discussions on the progress, challenges and future plans of the NRCSNBTS including the strategic plan developed with GAP.A review of the progress of the Blood Service to key challenges was undertaken and significant policy changesand issues were discussed, primarily including the revised national blood policy which permits new entrants toprovide blood in Nepal a significant shift in national direction. The role of the Ministry of Health in blood centreregulation and oversight, and the role of the Nepal Red Cross Society, in ensuring appropriate funding and selfsufficiency were discussed together with the recent WHO Essential medicines listing of blood and blood products.The team visited: Nepal Red Cross Society Central Blood Transfusion Service A district blood centre operated by the NRCS NBTS Tribhuvan University Teaching Hospital Blood Bank Centre Grande Private Hospital Blood BankThe equipment was funded by the Hong Kong Red Cross and was comprised of: Vertical Autoclave 100L (1) Manual Plasma Extractors (5) Stainless Steel sample racks, 48 tube capacity (25) Centrifuge Balance (1) Blood Refrigerator, 150 bag capacity (3)Dr Che Kit Lin (HKRC BTS) andDr Manita Rajkarnikar (Director,NRCS NBTS) showing the plaquesacknowledging equipment fundingfrom the Hong Kong Red Cross1112GAPANNUAL REPORT 2014GAPANNUAL REPORT 2014Training WorkshopsTwo training workshops were held for Nepal Red Cross Society Blood Service staff. The training participantsincluded technical representatives from the central, district and remote regional blood centres, and also includedparticipants from the Nepal Red Cross Society executive and management teams.Workshop 1: Blood donor care and counselling.The GAP delegation provided presentations to 28 participants on the donation process and targeted donor careand counselling recommendations, led by Dr Che Kit Lin. Participants performed donor counselling role playexercises, practising the techniques highlighted in the theory sessions. Each participant was provided with ahandbook outlining the material covered during the theory session together with additional reference information.It is intended that the handbooks may be circulated widely or used to base future internal training sessions withinthe NRCS NBTS and throughout the district and regional centres.Dr Che Kit Lin presenting at the training workshops in NepalWorkshop 2: The Risk Management Planning WorkshopThe workshop, which was attended by 47 participants, assisted the NRCS NBTS with the developmentof an appropriate risk management system by identifying key organisational risks which were capturedinto a risk register. A theoretical session on risk management was provided, followed by worked examplesand practical application of the risk management system to identify, prioritise and prepare treatment plansfor NRCS NBTS risks. Practical sessions were conducted in groups to assist in working through theprocess for risk management based on each particular area of technical expertise. A handbook outliningthe risk management system for further development and tailoring by the NRCS NBTS was providedto all participants, together with relevant reference material. The outcomes of the practical sessionsand group work were captured into a risk register, which was provided to the blood service Director.Development ForumA development forum was held where the 42 attendees (from NRCS NBTS executive/management,Nepals national Public Health Laboratories, IFRC, Nepal Red Cross Society, World Health Organisation,various embassies and UNICEF) were provided with presentations on National Blood System requirements,emerging policy issues, the progress of the national strategic plan, additional elements required for bestpractice and any current barriers to implementation. Group sessions and discussions were facilitated toengage the participants in the sessions, and to seek opportunities to leverage support and assistancefor the NRCS NBTS in achieving their strategic plan, and enabling delivery of an effective national bloodprogram for the people of Nepal.FeedbackParticipants at the training workshops in NepalDr Rajkarnikar reported at the GAP AsiaPacific regional meeting in September2014 that the training provided was highlyvalued and thanked GAP and the HongKong Red Cross for providing the bloodservice with this support. It was suggestedthat the materials provided during thetraining were so well regarded that theyshould be placed on the GAP websiteas a resource for other countries toaccess. As a result, the presentationshave been added to the GAP websiteand are available on the public pages.GAP team in Nepal with Dr ManitaRajkarnikar (Director, NRCS NBTS)ai1314GAPANNUAL REPORT 2014GAPANNUAL REPORT 20148.PRIORITY COUNTRIESNepalThe collaborative project between the Hong Kong Red Cross, Nepal Red Cross Society National Blood TransfusionService and GAP, completed during 2014, aimed to improve blood service capability through the provision of criticalequipment and staff training as well as guidance in the development of a risk management framework andimprovements to national policy and planning.In conjunction with the World Health Organisation (WHO) and Dr Che Kit Lin (GAP Asia Pacific Zonal Coordinator)and building on the outcomes of the 2014 Nepal training workshops, the Secretariat is coordinating a potential visitfor the Nepal Minister of Health and Nepal Red Cross Society Secretary General to visit Hong Kong and Australia.The purpose of the visit is to review well-functioning models within the region where National Society Blood Servicesoperate a single national blood program with government funding support*. The visit will enable the Nepal Ministryof Health and Secretary General to gain a detailed understanding of the governance, structural and operationalarrangements which support such models and which ensure effective and close cooperation with government.Nepals status as a GAP priority country will continue to be reviewed by the GAP Executive Board.The GAP website homepageGAP Website (IFRC Funding 2013-2014)The GAP website was developed to support GAP member, blood service and public access to materials,resources and tools and to provide users with direct links to GAP contacts and information.The development of the website was guided by member input from a user requirements survey which providedvaluable information on the content of the website that would be most useful to members. A detailed comparisonof potential website developers was undertaken, including consideration of critical factors such as security, cost,provision of ongoing maintenance, support and hosting arrangements, developer responsiveness, reputationand reliability.The Secretariat worked closely with the website developer during 2014 to finalise the design, features, content,security and access requirements.The GAP website was launched on 17th February 2015. Members were notified of the GAP website location,www.globaladvisorypanel.org and given their unique login to access the restricted member only pages on thesite. A link to the GAP website has been created on the IFRC Fednet website on the Blood Donation page.The website has: Public pages (open access) information about GAP and public events/tools GAP member pages (login required) restricted access documents, events and tools. Discussion forum - for members.15* The Nepal Government recently revised its blood policy to now permit agencies other than the Nepal Red Cross Society to provide blood.A number of national changes to the organisation, regulation and oversight of blood centres will be implemented in the near future and theaim of the visit is to show the Minister examples of effective models whereby the national blood program is delivered by RC/RC but fundedby government.BangladeshBangladesh was selected as a GAP priority country in May 2014, on the basis of their GAPSelf-assessment results in 2013, which identified a number of areas of potential significant risk.GAP delegates Dr Wolfgang Mayr and Ms Michelle Wsolak conducted an initial scoping visitof the Bangladesh Red Crescent Blood Service (BRCBS) from 24th 27th November, 2014.The purpose of the visit was to increase GAPs understanding of the Blood Service situationin Bangladesh, including the operational context of the Blood Service within the broader healthsector and coordination with other agencies, to assess and prioritise the key risk management and corporategovernance needs of the BRCBS in the provision of its blood program and to develop recommendations anda proposal for a future programme of GAP support to Bangladesh Red Crescent Blood Service for consideration.During the visit, the GAP delegates met key stakeholders in Bangladesh including: Dr Tarique Mehedi - Deputy Director and In-Charge BRCBS; Representatives from the Safe Blood Transfusion Expert Committee; WHO consultant - Dr Murad Sultan; Secretary General Bangladesh Red Crescent Society - BMM Mozharul Huq; IFRC country delegation Programme Coordinator Mr David Easson and Manager Health - Dr Abu Faruq.16GAPANNUAL REPORT 2014GAPANNUAL REPORT 2014HaitiThe priority country status of Haiti is currently on hold pending completion of their bilateral support programmes.IndonesiaThe priority country status of Indonesia is currently on hold pending completion of their bilateral support programmes.VietnamThe priority country status of Vietnam has been closed on the basis of information provided by the VietnamRed Cross that they are not involved in a Level A blood programme.Laboratory in HondurasGAP delegates in Bangladeshwith Bangladesh Red Crescent BloodService Deputy Director & In-ChargeDr Mehedi and WHO representative.The delegates also toured the BRCBS Dhaka Blood Centre Facility, a major maternity hospital blood bank(Mohammadbpur Fertility Services and Training Centre Dhaka) and attended a Voluntary Blood DonorCamp at Karwan Bazar sponsored by Bank Asia.A full report of the visit was provided to the BRCBS, including a number of prioritised recommendationsfor action, and proposed options for GAP support to BRCBS to assist in managing these key risk areas.The recommendations for the future of GAP support to Bangladesh are currently being finalised by GAPand the BRCBS Director.HondurasIn October 2013, a second workshop was held with Honduran Red Cross (HRC), Swiss Red Cross (SRC),and GAP to clarify the roles and responsibilities of HRC and prepare an action plan. Workshop outcomesincluded the development of a proposed new governing and organisational structure for the HonduranRed Cross National Society. In January 2014, GAP received advice from the Honduran Red Cross that theyhave adapted their governing structure according to GAPs recommendations, signalling significant progressin addressing this area of key risk. GAP has written to the HRC to formally endorse the proposed structure.GAP member Dr Rudolf Schwabe continues to support the bilateral project with Honduras, through the SwissRed Cross, to assist in strengthening the technical, administrative and governance capacity of the HonduranRed Crosss National Blood Program.1718GAPANNUAL REPORT 2014GAPANNUAL REPORT 20149. FINANCIAL REPORTGAP Income and Expenditure for period 1 January 2014 to 31 December 2014Opening balance at 1 January 2014NotesAUD accountCHF accountTotal CHFGAP accountsAustralian Account291,411Swiss Account236,693107,922107,922369,868107,922408,340AUD accountCHF accountTotal CHFIFRC Funding accountAustralian AccountCombined opening balance at 1 January 201478,457*Income63,7252014 Member ContributionsAmerica26,27721,343Australia26,34621,399Finland23,80919,339Israel24,96620,278Japan24,65420,025Switzerland25,29220,543Germany24,01019,502Austria24,81420,155Belgium25,34620,587Thailand24,99420,301250,508203,47177,58463,016Hong Kong - special statusHonduras - exemptsubtotal2014 IFRC funding IncomeIncome2014 Interest IncomeInterest- GAP Australian account11,555Interest - GAP Swiss account9,38544Interest - IFRC funding account2,805subtotal14,36023,831442,2784411,707Other IncomePayment from HKRC for Nepal Joint Project ContributionTotal IncomeExpenditure19,356366,28344297,550AUD AccountCHF AccountTotal CHFSecretariatSelf Assessment costsSecretariat costs#(40,354)(32,777)(89,906)(73,024)(125)(101)Specialist AdviceTranslation- Self assessment reports, GAP manual, questionnaireProfessional expertise eg legalStakeholder meetings (e.g. IFRC, WHO, ISBT)Travel & accommodationOther meeting expensesRegional meetingsMeeting costs269219(10,815)(8,785)Travel & accommodation(2,275)(1,848)Meeting venue/catering(3,457)(2,808)(907)(737)(3,324)(2,700)(16,637)(13,513)(21,413)(17,393)Participant costsAnnual General MeetingGAP networking events (dinner)Other expensesExecutive Board Meeting(s)Meeting venue/catering and travel accommodationTeleconferencesNepal (priority NS)GAP-HKRC Joint Project for Nepal - IFRC Funded ExpenditureGAP-HKRC Joint Project for Nepal - HKRC Funded ExpenditureHonduras (priority NS)Travel & accommodation(8,919)(8,919)Insurance(1,000)(1,000)Bank fees(72)(72)Other ExpensesContingency fundsIFRC funding expenditurePriority Country Support - Bangladesh(9,969)(8,097)(29,228)(23,740)Translation Costs(1,352)(1,098)Website Development(9,553)(7,759)Project SupportPriority Country Support - Nepal (Joint GAP Project with HKRC) refer aboveTotal Expenditure**(239,047)(9,991)Surplus/(Deficit)127,236(9,947)93,398Closing balance at 31 December 2014497,10497,975501,73819(204,152)Notes* Exchange rate as per XE Currency converter website 31 Dec 2014: 1 AUD = 0.8122324904 CHF** Cost Accrual not yet shown but fully expended. A further 6,476 CHF for Project Support will be incurred in January 2015.# Secretariat costs include salary and oncosts, phone, training, office supplies, postage, rent, other secretariat sundry expenses Cost incurred were for AUD 21,413 and invoice raised in Nov 2014 was for USD 20,132.47. Amount received in Dec 2014 wasfor AUD 23,831 as a result of exchange rate fluctuation as at date of payment.20
GAP Self-assessment (Spanish)
Grupo Mundial de Asesores en materia de estructura institucional y gestión de riesgo para las sociedades de la Cruz Roja y de la Media Luna Roja que participan en programas de sangre (GAP) Autoevaluación del GAP Versión 4.1 Diseñado para las Sociedades Nacionales que cuentan con servicios de sangre (nivel A) [INSERT MONTH ] de 2014 Si desea obtener más información y leer las instrucciones, consulte las guías de autoevaluación del GAP. País: Nombre del servicio de sangre: Nombre (s) persona (s) que completa la encuesta: Posición: Fecha en la que la completa: Una vez que la complete, envíe un correo electrónico a GAPSelfAssessment@redcrossblood.org.au (opción preferible) o envíela por fax al +61 8 6213 5949 Contenido Lista de acrónimos Sección A: cuestiones clave Cuestión clave Nº 1: condiciones mínimas Cuestión clave Nº 2: requisitos organizativos esenciales Cuestión clave Nº 3: protección contra los reclamos por daños y perjuicios Cuestión clave Nº 4: apoyo a las personas que reciben sangre infectada Cuestión clave Nº 5: la seguridad frente a los Cuestión clave Nº 6: financiación Cuestión clave Nº 7: información sobre los riesgos y las consecuencias relacionados con la sangre  Cuestión clave Nº 8: habilidades de gestión Cuestión clave Nº 9: fraccionamiento Sección B: generalidades sobre las actividades del servicio de Autosuficiencia del plasma Acuerdos bilaterales Próximos pasos recomendados Comentarios finales Lista de acrónimos AABB CdE Asociación American de Bancos de Sangre Consejo de Europa (Comité Europeo (acuerdo parcial) de transfusión sanguínea (CD-P-TS)) GAP Grupo Mundial de Asesores en materia de estructura institucional y gestión de riesgo de las sociedades de la Cruz Roja y de la Media Luna Roja que participan en programas de sangre Federación Internacional de sociedades de la Cruz Roja y de la Media Luna Roja Sociedad Nacional Autoevaluación del GAP Donación de sangre voluntaria y no remunerada Organización Mundial de la Salud FICR SN AE DSVNR OMS Sección A: Cuestiones clave Cuestión clave Nº 1: condiciones mínimas Aclaración: • Es importante que la gestión del servicio de sangre se base en los principios fundamentales de la FICR. • Las relaciones con las autoridades competentes del gobierno nacional y local deben estar claramente definidas para garantizar que el servicio de sangre siga siendo independiente. • La donación de sangre voluntaria y no remunerada es una política de la FICR; todos los servicios de sangre de las Sociedades Nacionales deberían contar con sistemas sanguíneos que se la DSVNR. • La implementación de un servicio de sangre debe incluir fuentes de ingresos sustentables y a largo plazo, así como instalaciones, suministros, equipo, personal y voluntarios suficientes que satisfagan las necesidades operativas. 1.1 ¿Se han establecido claramente las funciones y responsabilidades entre el servicio de sangre y Parcialment e (indique Sí No No se conoce No se aplica los detalles) el gobierno nacional los gobiernos locales la Sociedad Nacional Otras partes interesadas (por favor, especifique): por ejemplo, los hospitales Sírvase dar detalles: 1.1.1 Si la respuesta es SÍ, cómo se definen? (Seleccione todas las que apliquen) Memorando de entendimiento Contrato u Otros otro acuerdo (especifique a por escrito continuación) No se aplica el gobierno nacional los gobiernos locales la Sociedad Nacional Otras partes interesadas (por favor, especifique): por ejemplo, los hospitales Otro; especificar: 1.1.2 Si la respuesta es SÍ o Parcialmente: ¿las partes que se enumeran a continuación, asumen estas responsabilidades en forma activa? Sí Parcialment e (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica el gobierno nacional los gobiernos locales la Sociedad Nacional Otras partes interesadas (por favor, especifique): por ejemplo, los hospitales Sírvase dar detalles: 1.2 ¿El gobierno de su país cuenta con una política nacional orientada a garantizar el suministro de sangre segura a través de la donación de sangre voluntaria y no remunerada (DSVNR)? Sí Parcialment e (indique los detalles) Sírvase dar detalles: 1.2.1 Si Contestó SI o Parcialmente Se han implementado estas políticas?  Cuál es el nivel de la DVNRS en su país?  Existen iniciativas para incrementar la DVNRS? Sírvase dar detalles: 1.2.2 Si Contestó NO:  Cuál es el nivel de la DVNRS en su país?  Existen iniciativas para incrementar la DVNRS? Sírvase dar detalles: Cuestión clave Nº 1: condiciones mínimas (cont.) 1.3 ¿El servicio de sangre es una entidad legal independiente de la Sociedad Nacional? Sí Parcialment e (indique los detalles) No No se conoce No se aplica Sírvase dar detalles: 1.4 Si el gobierno no financia completamente su servicio de sangre, ¿usted cuenta con una fuente de ingresos a largo plazo, suficiente y sustentable? Sí No No se conoce Sírvase dar detalles: 1.4.1 Si no,  Porqué?  Existen planes para cambiar esto? Sírvase dar detalles: 1.5 ¿El servicio de sangre cuenta con los recursos suficientes de las categorías que se enumeran a continuación como para cumplir con los requisitos reglamentarios? Sí, son suficientes No, escasez No, escasez considerable leve (*Sírvase (*Sírvase proporcionar proporcionar más más información) información) No se conoce instalaciones *Si la respuesta es No, escasez leve o No, escasez considerable, esto podría indicar un riesgo considerable en relación con los materiales, así que le solicitamos que a continuación brinde información más detallada en lo que respecta a la escasez de instalaciones y si se han desarrollado planes para mejorar esto. suministros *Si la respuesta es No, escasez leve o No, escasez considerable, esto podría indicar un riesgo considerable en relación con los materiales, así que le solicitamos que a continuación brinde información más detallada en lo que respecta a la escasez de suministros y si se han desarrollado planes para mejorar esto. equipo *Si la respuesta es No, escasez leve o No, escasez considerable, esto podría indicar un riesgo considerable en relación con los materiales, así que le solicitamos que a continuación brinde información más detallada en lo que respecta a la escasez de equipo y si se han desarrollado planes para mejorar esto. personal/voluntarios capacitados *Si la respuesta es No, escasez leveoNo, escasez considerable, esto podría indicar un riesgo considerable en relación con los materiales, así que le solicitamos que a continuación brinde información más detallada en lo que respecta a la escasez de personal/voluntarios capacitados y si se han desarrollado planes para mejorar esto. Cuestión clave Nº 1: condiciones mínimas (cont.) 1.6 ¿El servicio de sangre es capaz de garantizar la plena privacidad y confidencialidad de la información relacionada con los donantes? Sí Parcialment e (indique los detalles) Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: No No se conoce No se aplica Cuestión clave Nº 2: requisitos organizativos esenciales Aclaración: El GAP recomienda que las Sociedades Nacionales que ofrecen un programa de sangre deben establecer un servicio de sangre separado que cuente con una junta profesional de gobierno al que se le haya delegado la responsabilidad de llevar a cabo las tareas de dirección estratégica y la supervisión del desempeño operativo. Las habilidades y los conocimientos particularmente útiles para los miembros de la junta incluyen los que se relacionan con la gestión médico-científica y las áreas económico-financiera, política y legal. 2.1 ¿La Sociedad Nacional cuenta con una junta de gobierno separada para el servicio de sangre a la que le hayan delegado responsabilidades y el control de la planificación estratégica y la gestión operativa, y que le hayan conferido la autoridad financiera sobre el programa de sangre? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No No se conoce Sírvase dar detalles: 2.1.1 Si la respuesta es SÍ, ¿La Sociedad Nacional tiene un sistema bien definido para delegar tareas que es claro en lo que respecta a la autoridad y la responsabilidad entre: Sí Parcialme nte (indique los detalles) la Sociedad Nacional y las juntas del servicio de sangre? la junta de los servicios de sangre y la gerencia de los servicios de sangre? Sírvase dar detalles: 2.1.2 Si la respuesta es SÍ, ¿Su servicio de sangre tiene las habilidades y los conocimientos para implementar y gestionar el cambio, mantener las funciones y responsabilidades estrictas y cumplir con sus responsabilidades según el Q2.1? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 2.2 Existe una estructura organizativa apropiada para la junta de gobierno del servicio de sangre? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 2.2.1 Si la respuesta es SÍ, Su servicio de sangre, ¿se basa en un modelo de organización a escala nacional? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Cuestión clave Nº 3: protección contra los reclamos por daños y perjuicios Aclaración: • Se prefiere que las Sociedades Nacionales cuenten con una cobertura de seguros para las actividades del programa de sangre. • Los servicios de sangre deben tener una definición clara de su relación con el gobierno y el papel que desempeña el gobierno en lo que respecta a proteger la Sociedad Nacional contra llos reclamos y los daños. • El cuidado adecuado de los pacientes que sufren efectos adversos como resultado de la terapia de transfusión de sangre representa un problema importante para la • Lo ideal es que los servicios de sangre participen en la capacitación de la población acerca de los posibles riesgos de las transfusiones. • Asimismo, deben llevar registros precisos y conservarlos de manera segura. 3.1 La protección del gobierno (legal/financiera), ¿prevé la prestación de servicios de sangre o de los bancos de sangre y tejidos? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica Sírvase dar detalles: 3.2 ¿Se ha establecido una estructura corporativa separada entre la Sociedad Nacional y el servicio Sí de sangre para proteger los fondos de la Sociedad Nacional contra los daños relacionados con la (especifiqu prestación de los servicios de sangre? e los detalles) 3.2a Si la respuesta es SÍ, o PARCIALMENTE: Parcialme nte (indique los detalles) Sírvase dar detalles: 3.3 ¿El servicio de sangre funciona de acuerdo con las normas internacionales (por ejemplo, OMS, AABB, CdE) en relación con los programas de sangre? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 3.3.1 Si la respuesta es SÍ, o PARCIALMENTE, ¿qué norma(s) utiliza el servicio de sangre? Sírvase dar detalles: 3.4 Cuando el servicio de sangre no cumple con las normas internacionales en cuanto a la ejecución de los programas de sangre, ¿se documenta el motivo? Sí Parcialme nte (indique los Sírvase dar detalles: 3.5 Cuando el servicio de sangre no cumple con las normas internacionales en cuanto a la ejecución de los programas de la sangre, ¿el gobierno reconoce y acepta el motivo? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 3.6 ¿El servicio de sangre realiza campañas con el objetivo de aumentar la conciencia pública acerca de: Sí Parcialme nte (indique los detalles) 1. el hecho de que no es posible tener un riesgo cero con la terapia de transfusión de sangre? 2. la necesidad de equilibrar el riesgo de transfusión con el riesgo de no realizar la transfusión? 3. los logros en lo que respecta a la mitigación de los riesgos y los riesgos restantes? Sírvase dar detalles: Cuestión clave Nº 3: protección contra los reclamos por daños y perjuicios (cont.) 3.6.1 Si la respuesta es SÍ, ¿Con qué frecuencia se llevan a cabo las campañas? Sírvase dar detalles: 3.7 ¿El servicio de sangre desarrolló los sistemas para informar a los médicos sobre los posibles riesgos de las transfusiones? Si la respuesta es afirmativa, ¿cómo? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica Sí, Sí, por lo periódicam menos una ente. vez por año. No No se conoce Parcialme nte (indique los detalles) No No se conoce Información en el sitio web Folletos Redes clínicas informales Reuniones regionales Participación en los comités de transfusión hospitalarios otro; especificar: Sírvase dar detalles: 3.8 ¿El servicio de sangre cuenta con una política de retención de registros de donantes y de donaciones? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 3.9 ¿El servicio de sangre, cuenta con una cobertura de seguros contra las posibles responsabilidades que figuran a continuación? Sí Parcialme nte (indique los detalles) pérdida de la propiedad responsabilidad civil responsabilidad en relación con la sangre y los hemoderivados responsabilidad de directores y funcionarios responsabilidad profesional fraude interno lesión de los donantes manipulación maliciosa del producto Sírvase dar detalles: 3.10 Si la respuesta es SÍ, ¿la cobertura del seguro es suficiente? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 3.11 ¿El servicio de sangre recibe asesoramiento profesional acerca de los niveles y los tipos de coberturas de seguros? 3.12 ¿El servicio de sangre recibe protección comercial o gubernamental en relación con las enfermedades que se transmiten a través de la sangre? Sí Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: No se aplica Cuestión clave Nº 4: apoyo a las personas que reciben sangre infectada Aclaración: : las Sociedades de la Cruz Roja y de la Media Luna Roja deben demostrar compasión por todas las personas que reciben sangre infectada. El servicio de sangre no se hace responsable del riesgo de infección, que es inherente a los productos sanguíneos. Sin embargo, es apropiado que la Sociedad Nacional les brinde apoyo a las personas que sufren este tipo de complicaciones. Esto puede incluir asistencia financiera, psicológica, médica o social. 4.1 ¿El servicio de sangre o el departamento de salud cuentan con un mecanismo para brindar asistencia a las personas que reciben sangre infectada? Sí Parcialme nte (indique los No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica Sírvase dar detalles: 4.1.1 Si contestó No, que agencia les brinda apoyo a estos Sírvase dar detalles: receptores? 4.2 ¿El servicio de sangre o el departamento de salud brindan una compensación económica a las personas que reciben sangre infectada? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 4.3 ¿El servicio de sangre o el departamento de salud brindan apoyo psicológico profesional a las personas que reciben sangre infectada? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 4.4 ¿El servicio de sangre o el departamento de salud proporcionan asistencia médica a las personas que reciben sangre infectada? Sí Parcialme nte (indique los Sírvase dar detalles: 4.5 ¿El servicio de sangre o el departamento de salud brindan apoyo social a las personas que reciben sangre infectada? Por ejemplo, en las conversaciones de apoyo acerca de los seguros de salud Sí Parcialme nte (indique los Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta Cuestión clave Nº 5: La seguridad frente a los costos Aclaración: • Estas preguntas abordan cuestiones relacionadas con el equilibrio entre la seguridad, el costo y la disponibilidad. • A pesar de que hay una tendencia continua hacia la mejora de la seguridad de los productos sanguíneos, es importante asegurarse de que no se esté reemplazando un riesgo pequeño con un riesgo desconocido que posiblemente sea mayor. Además, los esfuerzos para aumentar la seguridad pueden afectar la disponibilidad de productos sanguíneos en general. • Estar pendiente de las amenazas emergentes y de la capacitación de los organismos gubernamentales en lo que se refiere a las nuevas medidas de seguridad representan funciones importantes del servicio de sangre. • Los mecanismos de revisión para rastrear el uso del producto y asegurar que los componentes de la sangre se utilicen de manera adecuada dentro de los hospitales constituyen otra preocupación clave. 5.1 ¿El servicio de sangre realiza un análisis de costos de todas las nuevas propuestas destinadas a mejorar la seguridad? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce No No se conoce Sírvase dar detalles: 5.2 ¿El servicio de sangre informa activamente a los organismos gubernamentales acerca de la importancia de contar con una financiación adecuada para las nuevas iniciativas vinculadas con la seguridad de la sangre y las consecuencias de no financiarlas? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 5.3 ¿El servicio de sangre cuenta con sistemas para controlar las nuevas amenazas a la seguridad del suministro de sangre (por ejemplo, control de las enfermedades de la región)? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 5.4 ¿El servicio de sangre implementó sistemas para asegurar que se cumpla con los siguientes cuatro aspectos de la seguridad relacionados con las transfusiones de sangre (y asegurar el mejor resultado para el paciente): Sí Parcialme nte (indique los detalles) Se brinda la sangre correcta. Se brinda el producto al paciente correcto. Se brinda el producto en el momento correcto. Se cuenta con el mecanismo de revisión correcto. Sírvase dar detalles: Cuestión clave Nº 5: la seguridad frente a los costos (cont.) 5.5 ¿El servicio de sangre tiene como objetivo influir sobre el uso adecuado del producto, o acerca de su almacenamiento, tratamiento, desperdicio mínimo, etc.? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce Sírvase dar detalles: 5.5.1 Si la respuesta es SÍ, ¿Cómo? Especifique: indique el porcentaje de usuarios finales en relación con los cuales hay un acuerdo por escrito. 5.6 ¿Los hospitales que utilizan productos sanguíneos que provienen de su servicio de sangre cuentan con un comité multidisciplinario activo de transfusiones? Sí Parcialme nte (indique los detalles) Hospitales públicos Hospitales privados Hospitales sin fines de lucro Clínicas Fuerzas armadas otro; especificar: Sírvase dar detalles: 5.6a ¿Qué porcentaje del total nacional representan los siguientes usuarios: Hospitales públicos Hospitales privados Hospitales sin fines de lucro Clínicas Fuerzas armadas otro; especificar: 5.6.1 Si la respuesta es SÍ o PARCIALMENTE, ¿El servicio de sangre participa % % % % % % Sí No No se conoce Parcialme nte (indique los detalles) No comités? 5.7 ¿El servicio de sangre participa en el desarrollo de regulaciones, junto con las autoridades sanitarias competentes? Sí Sírvase dar detalles: 5.8 Aproximadamente, ¿qué porcentaje de su suministro de sangre proviene de donantes DSVNR? % No se conoce Cuestión clave Nº 5: la seguridad frente a los costos (cont.) Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Cuestión clave Nº 6: financiación Aclaración: Se deben implementar acuerdos financieros suficientes y  a largo plazo que debe revisar la sociedad local de la Cruz Roja o de la Media Luna Roja antes de iniciar o seguir participando en un programa de sangre. La mejor manera de asegurar finanzas sustentables es a través de la recuperación de los costos o la financiación del gobierno, aunque en algunas áreas se aceptaría el uso de donaciones. La transferencia de fondos entre las Sociedades Nacionales y los servicios de sangre deben realizarse en el marco de los acuerdos de servicio adecuados. La existencia de acuerdos financieros transparentes y sustentables dentro de los servicios de sangre, y entre el servicio de la sangre y de la sociedad de la Cruz Roja o de Media Luna Roja constituye una prioridad. 6.1 ¿Qué porcentaje de su presupuesto total de servicios de sangre proviene: Especifique el porcentaje en cada caso: 6.1.1 del gobierno % 6.1.2 de los hospitales % 6.1.3 la refacturación de los costos a los usuarios finales % 6.1.4 de las actividades de financiamiento internas % 6.1.5 de su Sociedad Nacional % 6.1.6 de otras Sociedades Nacionales % 6.1.7 de las ONG (organizaciones no gubernamentales) y los fondos internacionales % 6.1.8 del sistema de seguro de salud público/privado % 6.1.9 Otro (especificar): % 6.2 ¿El servicio de sangre asegura que ni las organizaciones sin fines de lucro ni los proveedores tienen participación alguna en el capital o en el control de la gestión del programa de sangre? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce Sírvase dar detalles: 6.3 ¿El servicio de sangre cuenta con una política para asegurar que no exista un conflicto de intereses con: Sí Parcialme nte (indique los detalles) los miembros de la junta el personal profesional los voluntarios Sírvase dar detalles: 6.4 ¿El servicio de sangre cuenta con una política para asegurar que no exista un conflicto de intereses en relación con los principales proveedores? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Cuestión clave Nº 6: Financiación (cont.) 6.5 ¿Existe un acuerdo formal para gestionar el acceso de la Sociedad Nacional a los fondos del servicio de sangre? 6.6 Sí; la SN no puede acceder a los fondos. Sí; el acuerdo formal le permite acceder a los fondos a la la SN, según corresponda. No No se conoce Otro : (Especifique los detalles a continuación) No se aplica Sírvase dar detalles: ¿Se separaron los fondos del servicio de sangre para que el servicio de sangre los utilice? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No se aplica Sírvase dar detalles: 6.7 ¿La Sociedad Nacional subsidia el servicio de sangre? Parcialme Sí nte (especifiq (indique ue los los detalles) detalles) Sírvase dar detalles: 6.8 ¿Los fondos del servicio de sangre se destinan a otras actividades de la Cruz Roja que no se relacionan con el servicio de sangre? Parcialme Sí nte (especifiq (indique ue los los detalles) detalles) Sírvase dar detalles: Cuestión clave Nº 6: Financiación (cont.) 6.9 ¿La Sociedad Nacional y el servicio de sangre llevan sistemas de contabilidad separados? Sí Parcialme nte (indique los detalles) No No se conoce Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: No se aplica Cuestión clave Nº 7: información sobre los riesgos y las consecuencias relacionados con la sangre Aclaración: : Es importante que los servicios de sangre de las Sociedades de la Media Luna Roja y de la Cruz Roja capaciten adecuadamente tanto al público en general como a las otras partes, tales como la  Sociedad Nacional, el gobierno, las universidades de medicina y el personal de los servicios de sangre con el fin de que comprendan mejor cuáles son los riesgos inherentes a las transfusiones de sangre. 7.1 ¿Los pacientes tienen que dar su consentimiento informado y por escrito antes de la transfusión? Sí Parcialme nte (indique los detalles) No No se conoce No se aplica No No se conoce No se aplica No No se conoce No No se conoce Sírvase dar detalles: 7.1.1 ¿El servicio de sangre trabaja junto con los hospitales para asegurar la iplementación de una política o de procedimientos que exijan que los pacientes den su consentimiento informado y por escrito antes de la transfusión? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 7.2 ¿El servicio de sangre desarrolló e implementó estrategias destinadas a mejorar la información que recibe el público en relación con la seguridad de los riesgos de la donación y las transfusiones de sangre? Sí Parcialme nte (indique los detalles) Programas escolares Medios (incluidos los medios de comunicación social) Información en el sitio web Folletos Redes informales La capacitación de los donantes La ubicación de representantes en los órganos adecuados de toma de Otro (especificar): Sírvase dar detalles: 7.2.1 ¿Las estrategias mencionadas se están implementando? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Cuestión clave Nº 7: información sobre los riesgos y las consecuencias relacionados con la sangre (cont.) 7.3 ¿El servicio de sangre brinda capacitación sobre los riesgos de la transfusión de sangre a otras partes interesadas, tales como: Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce la Sociedad Nacional del gobierno universidades de medicina personal del servicio de sangre Otro (especificar): Sírvase dar detalles: 7.4 ¿El servicio de sangre realiza campañas periódicas para educar al público acerca de la necesidad de donar sangre con regularidad? Parcialme Sí nte (especifiq (indique ue los los detalles) detalles) Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Cuestión clave Nº 8: Habilidades de gestión Aclaración: Con el fin de lograr y mantener un buen nivel de gestión en los servicios de sangre de la Sociedad Nacional, se debe contar con una visión y una misión claras, objetivos estratégicos, así como medios para medir el progreso hacia la consecución de estos objetivos. 8.1 ¿El servicio de sangre tiene lo siguiente? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce una visión clara una misión clara un plan estratégico objetivos estratégicos Sírvase dar detalles: 8.2 Si los hay, ¿los objetivos estratégicos del servicio de sangre: Sí Parcialme nte (indique los detalles) establecen responsabilidades claras abordan las necesidades del donante abordan las necesidades del receptor abordan las necesidades del médico Sírvase dar detalles: 8.3 ¿Se han establecido y puesto en práctica objetivos e indicadores clave de desempeño (por ejemplo, porcentaje de disminución en el tiempo de lesiones del personal, porcentaje de disminución del desperdicio del producto)? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Cuestión clave Nº 8: habilidades de gestión (cont.) 8.4 ¿Existen programas de capacitación orientados a mantener y desarrollar las habilidades de gestión y liderazgo? Sí Parcialme nte (indique los detalles) No No se conoce Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Cuestión clave Nº 9: fraccionamiento Aclaración: • En los países desarrollados, no es conveniente que la Cruz Roja / Media Luna Roja comience a realizar actividades de fraccionamiento por el riesgo de descartes masivo, a menos que la escala de la operaciones en ese país permita que sea viable. • En los países en desarrollo, la Sociedad Nacional puede considerar la posibilidad de llevar a cabo el fraccionamiento si esta es la única manera de obtener productos derivados del plasma, pero solo si se obtiene el apoyo adecuado de la autoridad gubernamental. • Si se debe descartar el plasma, se les debe advertir a los donantes. • Antes de que las Sociedades Nacionales fraccionen o tercericen la tarea a otros fraccionadores, las autoridades gubernamentales competentes deben aprobar la fabricación y los procesos de comercialización del producto. • La posición de la FICR es que la autosuficiencia de un país es un asunto de la política del gobierno de ese país. 9.1 ¿El gobierno cuenta con una política nacional de autosuficiencia en relación con los productos sanguíneos que incluye los productos de plasma? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce No No se conoce Sírvase dar detalles: 9.2 ¿El servicio de sangre opera una o más plantas de fraccionamiento? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 9.2.1 ¿El servicio de sangre o la Sociedad Nacional planean participar de alguna manera en la operación de plantas de fraccionamiento en el futuro inmediato? Sí Parcialme nte (indique los Sírvase dar detalles: 9.3 ¿El servicio de sangre o la Sociedad Nacional envían plasma para que un fraccionador externo lo fraccione? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Cuestión clave 9: Fraccionamiento (cont.) 9.3.1 Si la respuesta es la respuesta es No, ¿el servicio de sangre o la Sociedad Nacional planea comenzar a enviar plasma para su fraccionamiento? Sí Parcialme nte (indique los detalles) No No se conoce No No se conoce No No se conoce No No se conoce Sírvase dar detalles: 9.4 Si el servicio de la sangre o la Sociedad Nacional llevan a cabo actividades de fraccionamiento de plasma, ¿el servicio de sangre informa a los donantes cuando se desecha el plasma? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 9.5 Si el servicio de sangre o la Sociedad Nacional llevan a cabo actividades de fraccionamiento de plasma, ¿se trata de una actividad transparente y se rinde cuentas frente a los donantes? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: 9.5.1 Si la respuesta es SÍ o PARCIALMENTE, ¿qué hace el servicio de sangre Sírvase dar detalles: para garantizar la transparencia y la rendición de cuentas? 9.6 Si el servicio de sangre o la Sociedad Nacional llevan a cabo actividades de fraccionamiento de plasma o envían plasma para su fraccionamiento a una planta de fraccionamiento externa, ¿se cuenta con la aprobación oficial del gobierno con respecto al proceso de fabricación o comercialización? Sí Parcialme nte (indique los detalles) Sírvase dar detalles: Si lo desea, puede incluir otros comentarios o información adicional para aclarar sus respuestas con respecto a esta sección: Sección B: Generalidades sobre las actividades del servicio de sangre  Por favor proporcione una breve descripción de su servicio de sangre y los datos más recientes a los que usted tenga acceso. Esta sección le ayudará a establecer un panorama general de las actividades relacionadas con la sangre en su Sociedad Nacional, y ayudar a evaluar el progreso en el tiempo. País Nombre de la organización Año de inicio del servicio de sangre Número de empleados de la Sociedad Nacional involucrados en el servicio de sangre (no los miembros del personal del hospital) Presupuesto anual actual Especifique año al que se refiere este presupuesto (especificar mes y año de inicio y de finalización) 0 0 [Especificar la moneda] a Desde Si hay otros proveedores de servicios de sangre en su país, sírvase enumerarlos (por ejemplo, los cinco proveedores principales)       junto con el porcentaje aproximado de participación en la cobertura del servicio en general: Nombre                         % de participación 1. 2. 3. 4. 5. Por favor adjunte su: estructura de gobierno organigrama Socios que prestan apoyo técnico (especificar) Número de lugares fijos Número de lugares móviles Número total de tomas por año* Cantidad de sangre total por año * De corresponder, indique el número de extracciones de aféresis: -> Plasma (unidades de aféresis de plasma al año) -> Plaquetas Unidades ml por unidad -> Los glóbulos rojos (unidades de aféresis de plaquetas/año) De corresponder, especifique la cantidad anual de plasma destinado al fraccionamiento* (en toneladas): * Si el año de las extracciones difiere al del presupuesto, especifique el año al que se refieren las extracciones [Insertar el mes/el año] [Insertar el mes/el año] a: a Autosuficiencia del plasma ¿La cantidad de plasma para fraccionamiento es suficiente para satisfacer las necesidades de su país? Sí No Si la respuesta es No,, Por favor indique los 5 productos de fraccionamiento principales por fuente: Producto 1. 2. 3. 4. 5. Importado de País Empresa Sección B: generalidades sobre las actividades de los servicios de sangre (cont.) ¿Usted tiene un excedente de plasma o productos de plasma?             Si la respuesta es SÍ, ¿qué ocurre con los productos excedentes? descartado vendido a [Especificar el país] [Especificar el país] vendido a Otro; especificar:       Si se venden diferentes productos a diferentes países, especifique a continuación: Sí No para recuperar el costo para obtener una gan       ¿Su servicio de sangre participa actualmente de cualquiera de las siguientes terapias con células o tejidos? Sí No Células madre del cordón umbilical Células madre de sangre periférica Células madre de médula ósea Trasplante de órganos macizos Hueso Córnea Otro (especificar): Si la respuesta es SÍ, indique el nivel y tipo de actividad y el alcance de la participación (por ejemplo, Registry Collection / cosecha, el procesamiento, el almacenamiento, las pruebas) ¿Su servicio de sangre está planificando participar en cualquiera de las siguientes terapias de células o tejidos en los próximos uno a dos años? Sí No Células madre del cordón umbilical Células madre de sangre periférica Células madre de médula ósea Trasplante de órganos macizos Hueso Córnea Otro (especificar): Si la respuesta es SÍ, indique los detalles de la actividad prevista y el alcance de la participación (por ejemplo, Registry Collection / cosecha, el procesamiento, el almacenamiento, las pruebas) Sección B: generalidades sobre las actividades de los servicios de sangre (cont.) Acuerdos bilaterales ¿Participa de algún programa de apoyo bilateral en relación con su servicio de sangre? Sí No Si SÍ, indique los detalles: ¿Recibe fondos de otras fuentes para respaldar los acuerdos bilaterales? Sí No Si la respuesta es SÍ, indique los detalles: Historias de éxito ¿Estaría dispuesto a compartir algunas de sus historias de éxito local con otros servicios de sangre de la Cruz Roja Media Luna Roja? Sí No Próximos pasos Próximos pasos recomendados El objetivo de la autoevaluación es permitirles a las Sociedades Nacionales y sus servicios de salud que identifiquen los problemas a los que se les debe prestar más atención. Cada pregunta de la AE describe una condición que, si no se cumple, representa un riesgo para el servicio de sangre y su SN. Un plan que aborde cada una de las condiciones que no se cumplen, comenzando con aquellas que se incluyen en la cuestión clave Nº 1, deberían reducir considerablemente el nivel de riesgo del servicio de sangre y de la Sociedad Nacional. Para ayudar al servicio de sangre a enfrentar los riesgos que se identificaron, el GAP le brindará un informe de autoevaluación individual que contenga recomendaciones para gestionar los riesgos. Mientras tanto, el GAP recomendó una variedad de “próximos pasos” para que tenga en cuenta el servicio de sangre: Gobierno y gerencia  Establecer un grupo de trabajo junto con la Sociedad Nacional o con el servicio de sangre para revisar la estructura de gobierno y la gerencia actuales, y preparar un plan estratégico.  Pensar en la posibilidad de obtener asistencia o asesoramiento especializado en relación con cuestiones de gobernanza y gerencia de parte de otras Sociedades Nacionales o servicios de sangre, o contratar un asesor externo especializado en la materia.  El grupo de trabajo o el asesor podrían considerar lo siguiente: ○ si la estructura actual ofrece la supervisión adecuada y si las responsabilidades están claramente definidas; ○ si debería separarse la gerencia del servicio de sangre y la de la Sociedad Nacional; ○ si el servicio de sangre debería formar parte de una entidad legal separada de la Sociedad Nacional; ○ una estructura que incluya una junta de supervisión (que cuente con funciones de supervisión estratégica); ○ un máximo responsable ejecutivo (responsable de las gestiones diarias y de presentar informes ante la junta) y ○ un equipo de gerentes experimentados (que responda ante el máximo responsable ejecutivo) podría funcionar. Gestión de problemas legales y riesgos  Identificar las bases legislativas y normativas que rigen las operaciones del servicio de sangre. Evaluar si las leyes y normas actuales: ○ establecen con precisión cuál es la relación entre la gerencia del servicio de sangre y las autoridades gubernamentales; ○ regulan las actividades del servicio de manera adecuada; ○ le brindan alguna protección o indemnización frente a los reclamos legales.  Considerar si es necesario modificar las leyes y cuál es la mejor manera de lograr tales modificaciones.  Considerar la posibilidad de conversar con el gobierno y con las autoridades sanitarias competentes con el fin de obtener su apoyo en relación con esas propuestas.  Crear un equipo de gestión de riesgos dentro del servicio de sangre con el objetivo de que evalúen las actividades del servicio y preparen las políticas para identificar, minimizar y eliminar riesgos. Financiación y seguro  Revisar cuáles son las fuentes de financiación y los posibles flujos de ingresos. Evaluar si los contratos de servicios actuales (si los hubiera) con la Sociedad Nacional y los organismos públicos son suficientes o si es necesario modificarlos.  Solicitar asesoramiento acerca de la disponibilidad y el costo de obtener una cobertura de riesgos integral para el servicio y el personal. Políticas y estándares  Realizar una auditoría operativa con el fin de evaluar el grado de cumplimiento con los estándares de los programas de sangre internacionales. Identificar cuáles son los pasos que se deben realizar para mejorar el cumplimiento.  Revisar las políticas operativas (por ejemplo, las políticas para seleccionar y capacitar al personal, conservar documentos, las relacionadas con el consentimiento fundamentado de los pacientes, la información que se le brinda al público y las relaciones con los medios de comunicación, entre otros).  Establecer prioridades y revisar de manera sistemática las cuestiones y los puntos clave de la autoevaluación e incorporarlos en la política y los materiales de planificación.  Repetir la autoevaluación en forma periódica para verificar el avance. Comentarios finales Comentarios finales: El Grupo Mundial de Asesores agradece los comentarios relacionados con el proceso de completar esta autoevaluación. Estamos interesados ​en conocer quiénes participaron, recibir sugerencias o cualquier comentario adicional. GRACIAS Muchas gracias por su participación en la autoevaluación. Si usted tiene alguna otra información o retroalimentación que usted desea ofrecer, por favor, dirigirse por correo electrónico a: GAPSelfAssessment@redcrossblood.org.au Recibirá su informe de comentarios individual una vez que se termine el proceso de autoevaluación dentro de su región.
GAP Self-assessment (Arabic)
‫اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ )‪ (GAP‬ﻋﻠﻰ ﺣوﻛﻣﺔ اﻟﺷرﻛﺎت وإدارة اﻟﻣﺧﺎطر ﻟﺧدﻣﺎت اﻟدم ﻓﻲ ﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب‬ ‫اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر‬ ‫اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ‪GAP‬‬ ‫اﻹﺻدار ‪4.1‬‬ ‫ﻣﺻﻣﻣﺔ ﻟﻠﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ اﻟﻌﺎﻣﻠﺔ ﻓﻲ ﺧدﻣﺎت اﻟدم )اﻟﻣﺳﺗوى أ(‬ ‫]إدراج ﺷﮭر[ ‪2014‬‬ ‫ﯾرﺟﻰ اﻟرﺟوع إﻟﻰ إرﺷﺎدات اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ‪ GAP‬ﻟﻠﻣﻌﻠوﻣﺎت اﻟﻌﺎﻣﺔ واﻟﺗﻌﻠﯾﻣﺎت‬ ‫اﻟدوﻟﺔ‪:‬‬ ‫اﺳم ﺧدﻣﺔ اﻟدم‪:‬‬ ‫اﺳم )اﺳﻣﺎء( اﻷﺷﺧﺎص اﻟذﯾن ﯾﺳﺗﻛﻣﻠون اﻻﺳﺗﺑﯾﺎن‪:‬‬ ‫اﻟﻣﻧﺻب‪:‬‬ ‫ﺗﺎرﯾﺦ اﻹﻧﺗﮭﺎء‪:‬‬ ‫وﺑﻣﺟرد اﻻﻧﺗﮭﺎء‪،‬‬ ‫ﯾرﺟﻰ إرﺳﺎﻟﮫ ﻋﺑر اﻟﺑرﯾد اﻹﻟﻛﺗروﻧﻲ ‪) GAPSelfassessment@redcrossblood.org.au‬ﯾُﻔﺿل(‬ ‫أو اﻟﻔﺎﻛس إﻟﻰ ‪5949 6213 8 61+‬‬ ‫اﻟﻣﺣﺗوﯾﺎت‬ ‫ﻗﺎﺋﻣﺔ اﻻﺧﺗﺻﺎرات‬ ‫اﻟﻘﺳم أ ‪ -‬اﻟﻘﺿﺎﯾﺎ اﻟرﺋﯾﺳﯾﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :1‬اﻟﺣد اﻷدﻧﻰ ﻣن اﻟﺷروط‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :2‬اﻟﻣﺗطﻠﺑﺎت اﻟﺗﻧظﯾﻣﯾﺔ اﻷﺳﺎﺳﯾﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :3‬ﺣﻣﺎﯾﺔ ﺿد اﻟﻣطﺎﻟﺑﺎت ﻋن اﻷﺿرار‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :4‬اﻟدﻋم ﻟﻠﻣﺗﻠﻘﯾن ﻟﻠدم اﻟﻣﻠوث‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :5‬اﻟﺳﻼﻣﺔ ﻣﻘﺎﺑل اﻟﺗﻛﻠﻔﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :6‬اﻟﺗﻣوﯾل‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :7‬اﻟﻣﻌرﻓﺔ ﺑﺷﺄن ﻣﺧﺎطر اﻟدم وﻋواﻗﺑﮫ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :8‬اﻟﻣﮭﺎرات اﻹدارﯾﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :9‬اﻟﺗﻘﺳﯾم‬ ‫اﻟﻘﺳم ب ‪ -‬ﻧظرة ﻋﺎﻣﺔ ﻋﻠﻰ أﻧﺷطﺔ ﺧدﻣﺎت اﻟدم‬ ‫اﻻﻛﺗﻔﺎء اﻟذاﺗﻲ ﻟﻠﺑﻼزﻣﺎ‬ ‫اﻻﺗﻔﺎﻗﯾﺎت اﻟﺛﻧﺎﺋﯾﺔ‬ ‫اﻟﺧطوات اﻟﻣﻘﺑﻠﺔ اﻟﻣوﺻﻰ ﺑﮭﺎ‬ ‫اﻟﺗﻌﻠﯾﻘﺎت اﻟﻧﮭﺎﺋﯾﺔ‬ ‫ﻗﺎﺋﻣﺔ اﻻﺧﺗﺻﺎرات‬ ‫‪AABB‬‬ ‫‪CofE‬‬ ‫اﻟﺟﻣﻌﯾﺔ اﻷﻣرﯾﻛﯾﺔ ﻟﺑﻧوك اﻟدم‬ ‫ﻣﺟﻠس أوروﺑﺎ )اﻟﻠﺟﻧﺔ اﻷوروﺑﯾﺔ )اﻻﺗﻔﺎق اﻟﺟزﺋﻲ( ﻋﻠﻰ ﻧﻘل اﻟدم )‪((CD-P-TS‬‬ ‫‪GAP‬‬ ‫اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ ﻟﺣوﻛﻣﺔ اﻟﺷرﻛﺎت وإدارة ﻣﺧﺎطر‬ ‫ﺧدﻣﺎت اﻟدم ﻓﻲ ﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر‬ ‫اﻻﺗﺣﺎد اﻟدوﻟﻲ ﻟﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ‪GAP‬‬ ‫اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل‬ ‫ﻣﻧظﻣﺔ اﻟﺻﺣﺔ اﻟﻌﺎﻟﻣﯾﺔ‬ ‫‪IFRC‬‬ ‫‪NS‬‬ ‫‪SA‬‬ ‫‪VNRBD‬‬ ‫‪WHO‬‬ ‫اﻟﻘﺳم أ ‪ -‬اﻟﻘﺿﺎﯾﺎ اﻟرﺋﯾﺳﯾﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 1‬اﻟﺣد اﻷدﻧﻰ ﻣن اﻟﺷروط‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪:‬‬ ‫• ﻣن اﻟﻣﮭم أن إدارة ﺧدﻣﺎت ﻧﻘل اﻟدم ﺗﻌﺗﻣد ﻋﻠﻰ اﻟﻣﺑﺎدئ اﻷﺳﺎﺳﯾﺔ ﻟﻼﺗﺣﺎد اﻟدوﻟﻲ ﻟﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر ‪.IFRC‬‬ ‫• اﻟﻌﻼﻗﺔ ﻣﻊ اﻟﺳﻠطﺔ اﻟﺣﻛوﻣﯾﺔ اﻟوطﻧﯾﺔ واﻟﻣﺣﻠﯾﺔ ذات اﻟﺻﻠﺔ ﯾﻧﺑﻐﻲ أن ﺗﺣدد ﺑوﺿوح ﻟﺿﻣﺎن ﺑﻘﺎء ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﺳﺗﻘﻠﺔ‪.‬‬ ‫• ﯾﻌد اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪ (VNRBD‬ﺳﯾﺎﺳﺔ ﻣن ﺳﯾﺎﺳﺎت اﻻﺗﺣﺎد اﻟدوﻟﻲ ﻟﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر ‪ ،IFRC‬وﯾﻧﺑﻐﻲ أن ﯾﻛون ﻟدى ﺟﻣﯾﻊ ﺧدﻣﺎت اﻟدم اﻟﺗﺎﺑﻌﺔ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻧظم‬ ‫ﻧﻘل اﻟدم ﻋﻠﻰ أﺳﺎس ‪.VNRBD‬‬ ‫• ﯾﻧﺑﻐﻲ أن ﯾﺷﻣل إﻧﺷﺎء داﺋرة ﻧﻘل اﻟدم ﻣﺻﺎدر ﻋﻠﻰ اﻟﻣدى اﻟطوﯾل وﻣﺳﺗداﻣﺔ ﻟﻠدﺧل‪ ،‬ﻓﺿﻼ ﻋن ﻣراﻓﻖ ﻛﺎﻓﯾﺔ وإﻣدادات وﻣﻌدات وﻣوظﻔﯾن وﻣﺗطوﻋﯾن ﻟﺗﻠﺑﯾﺔ اﻻﺣﺗﯾﺎﺟﺎت اﻟﺗﺷﻐﯾﻠﯾﺔ‪.‬‬ ‫‪ 1.1‬ھل اﻷدوار واﻟﻣﺳؤوﻟﯾﺎت ﻗد ﺗم ﺗوﺿﯾﺣﮭﺎ ﺑﯾن ﺧدﻣﺔ ﻧﻘل اﻟدم و‬ ‫ﻧﻌم‬ ‫اﻟﺣﻛوﻣﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺣﻛوﻣﺎت اﻟﻣﺣﻠﯾﺔ‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺟﮭﺎت اﻟﻣﻌﻧﯾﺔ اﻷﺧرى )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪ :‬ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل‪ ،‬اﻟﻣﺳﺗﺷﻔﯾﺎت‬ ‫‪1.1.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﻛﯾف ﯾﺗم ﺗﺣدﯾدھﺎ؟ )ﯾرﺟﻰ اﺧﺗﯾﺎر ﻛل ﻣﺎ ﯾﻧطﺑﻖ(‬ ‫اﻟﺣﻛوﻣﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺣﻛوﻣﺎت اﻟﻣﺣﻠﯾﺔ‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺟﮭﺎت اﻟﻣﻌﻧﯾﺔ اﻷﺧرى )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪ :‬ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل‪ ،‬اﻟﻣﺳﺗﺷﻔﯾﺎت‬ ‫‪1.1.2‬‬ ‫ﻣذﻛرة اﻟﺗﻔﺎھم‬ ‫‪1.2‬‬ ‫ﻋﻘد أو اﺗﻔﺎق‬ ‫آﺧر ﻣﻛﺗوب‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﺗﺣدﯾد ذﻟك أدﻧﺎه( ﻟﻠﺗطﺑﯾﻖ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬أو ﺟزﺋﯾﺎ‪ :‬ھل ﯾﺗﻌﯾن اﻟﺗﻘﯾد ﺑﮭذه اﻷدوار واﻟﻣﺳؤوﻟﯾﺎت ﺑﺷﻛل ﻓﻌﺎل‪:‬‬ ‫ھل ﻟدى ﺣﻛوﻣﺔ ﺑﻠدﻛم ﺳﯾﺎﺳﺔ وطﻧﯾﺔ ﻟﺗﺄﻣﯾن إﻣدادات اﻟدم اﻟﻣﺄﻣون ﻣن ﺧﻼل اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون‬ ‫ﻣﻘﺎﺑل )‪?(VNRBD‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‬ ‫ﻧﻌم‬ ‫اﻟﺣﻛوﻣﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺣﻛوﻣﺎت اﻟﻣﺣﻠﯾﺔ‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺟﮭﺎت اﻟﻣﻌﻧﯾﺔ اﻷﺧرى )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪ :‬ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل‪ ،‬اﻟﻣﺳﺗﺷﻔﯾﺎت‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل( ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل( ﻻ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 1‬اﻟﺣد اﻷدﻧﻰ ﻣن اﻟﺷروط )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪1.2.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬أو ﺟزﺋﯾﺎ‪:‬‬ ‫ھل ﻗد ﺗم ﺗﻧﻔﯾذ ھذه اﻟﺳﯾﺎﺳﺎت؟‬ ‫‪ ‬ﻣﺎ ھو ﻣﺳﺗوى اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪ (VNRBD‬ﻓﻲ ﺑﻠدﻛم؟‬ ‫‪ ‬ھل ھﻧﺎك ﺧطوات ﻣطﺑﻘﺔ ﻟزﯾﺎدة اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪(VNRBD‬؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪1.2.2‬‬ ‫إذا ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪:‬‬ ‫‪ ‬ﻣﺎ ھو ﻣﺳﺗوى اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪ (VNRBD‬ﻓﻲ ﺑﻠدﻛم؟‬ ‫‪ ‬ھل ھﻧﺎك ﺧطوات ﻣطﺑﻘﺔ ﻟزﯾﺎدة اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون ﻣﻘﺎﺑل )‪(VNRBD‬؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪1.3‬‬ ‫ھل ﺧدﻣﺔ ﻧﻘل اﻟدم ﻛﯾﺎن ﻗﺎﻧوﻧﻲ ﻣﻧﻔﺻل ﻋن اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ؟‬ ‫‪1.4‬‬ ‫إذا ﻛﺎﻧت اﻟﺣﻛوﻣﺔ ﻻ ﺗﻣول ﺑﺎﻟﻛﺎﻣل ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك‪ ،‬ھل ﻟدﯾك ﻣﺻدر طوﯾل اﻷﻣد وﻛﺎف‬ ‫وﻣﺳﺗدام ﻟﻠدﺧل؟‬ ‫‪1.4.1‬‬ ‫إن ﻟم ﯾﻛن‪،‬‬ ‫‪ ‬ﻟﻣﺎذا؟‬ ‫‪ ‬ھل ھﻧﺎك ﺧطط ﻣطﺑﻘﺔ ﻟﺗﻐﯾﯾر ھذا؟‬ ‫‪1.5‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﺎ ﯾﻛﻔﻲ ﻣن اﻟﻣوارد اﻟﺗﺎﻟﯾﺔ ﻟﺗﻠﺑﯾﺔ اﻟﻣﺗطﻠﺑﺎت اﻟﺗﻧظﯾﻣﯾﺔ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل( ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‪ ،‬ﻛﺎﻓﯾﺔ‬ ‫ﻻ‪ ،‬ﻧﻘص طﻔﯾف‬ ‫) *ﯾرﺟﻰ ﺗﻘدﯾم‬ ‫ﻣزﯾد ﻣن‬ ‫اﻟﻣﻌﻠوﻣﺎت(‬ ‫ﻻ‪ ،‬ﻧﻘص ﻛﺑﯾر‬ ‫) *ﯾرﺟﻰ ﺗﻘدﯾم‬ ‫ﻣزﯾد ﻣن‬ ‫اﻟﻣﻌﻠوﻣﺎت(‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻣراﻓﻖ‬ ‫*إذا "ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻧﻘص طﻔﯾف" أو "ﻻ‪ ,‬ﻧﻘص ﻛﺑﯾر"‪ ,‬وھذا ﯾﻣﻛن أن ﯾﺷﯾر إﻟﻰ وﺟود ﻣﺧﺎطر ﻣﺣﺗﻣﻠﺔ ﻟﻠﻣواد‬ ‫اﻟرﺋﯾﺳﯾﺔ )‪ ،(MMR‬ﻟذا ﯾرﺟﻰ ﺗﻘدﯾم ﻣﻌﻠوﻣﺎت أﻛﺛر ﺗﻔﺻﯾﻼ أدﻧﺎه ﺑﺧﺻوص ﻧﻘص اﻟﻣراﻓﻖ وﻋﻣﺎ إذا ﻛﺎﻧت ھﻧﺎك‬ ‫ﺧطط ﻣﻌﻣول ﺑﮭﺎ ﻟﺗﺣﺳﯾن ھذا‪.‬‬ ‫اﻹﻣدادات‬ ‫*إذا "ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻧﻘص طﻔﯾف" أو "ﻻ‪ ,‬ﻧﻘص ﻛﺑﯾر"‪ ,‬وھذا ﯾﻣﻛن أن ﯾﺷﯾر إﻟﻰ وﺟود ﻣﺧﺎطر ﻣﺣﺗﻣﻠﺔ ﻟﻠﻣواد‬ ‫اﻟرﺋﯾﺳﯾﺔ )‪ ،(MMR‬ﻟذا ﯾرﺟﻰ ﺗﻘدﯾم ﻣﻌﻠوﻣﺎت أﻛﺛر ﺗﻔﺻﯾﻼ أدﻧﺎه ﺑﺧﺻوص ﻧﻘص اﻹﻣدادات وﻋﻣﺎ إذا ﻛﺎﻧت ھﻧﺎك‬ ‫ﺧطط ﻣﻌﻣول ﺑﮭﺎ ﻟﺗﺣﺳﯾن ھذا‪.‬‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 1‬اﻟﺣد اﻷدﻧﻰ ﻣن اﻟﺷروط )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪1.5‬‬ ‫)ﻣﺗﺎﺑﻌﺔ(‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﺎ ﯾﻛﻔﻲ ﻣن اﻟﻣوارد اﻟﺗﺎﻟﯾﺔ ﻟﺗﻠﺑﯾﺔ اﻟﻣﺗطﻠﺑﺎت اﻟﺗﻧظﯾﻣﯾﺔ؟‬ ‫ﻧﻌم‪ ،‬ﻛﺎﻓﯾﺔ‬ ‫اﻟﺗﺟﮭﯾزات‬ ‫ﻻ‪ ،‬ﻧﻘص طﻔﯾف‬ ‫) *ﯾرﺟﻰ ﺗﻘدﯾم‬ ‫ﻣزﯾد ﻣن‬ ‫اﻟﻣﻌﻠوﻣﺎت(‬ ‫ﻻ‪ ،‬ﻧﻘص ﻛﺑﯾر‬ ‫) *ﯾرﺟﻰ ﺗﻘدﯾم‬ ‫ﻣزﯾد ﻣن‬ ‫اﻟﻣﻌﻠوﻣﺎت(‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫*إذا "ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻧﻘص طﻔﯾف" أو "ﻻ‪ ,‬ﻧﻘص ﻛﺑﯾر"‪ ,‬وھذا ﯾﻣﻛن أن ﯾﺷﯾر إﻟﻰ وﺟود ﻣﺧﺎطر ﻣﺣﺗﻣﻠﺔ ﻟﻠﻣواد‬ ‫اﻟرﺋﯾﺳﯾﺔ )‪ ،(MMR‬ﻟذا ﯾرﺟﻰ ﺗﻘدﯾم ﻣﻌﻠوﻣﺎت أﻛﺛر ﺗﻔﺻﯾﻼ أدﻧﺎه ﺑﺧﺻوص ﻧﻘص اﻟﺗﺟﮭﯾزات وﻋﻣﺎ إذا ﻛﺎﻧت ھﻧﺎك‬ ‫ﺧطط ﻣﻌﻣول ﺑﮭﺎ ﻟﺗﺣﺳﯾن ھذا‪.‬‬ ‫اﻟﻣوظﻔون‪/‬اﻟﻣﺗطوﻋون اﻟﻣدرﺑون‬ ‫*إذا "ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻧﻘص طﻔﯾف" أو "ﻻ‪ ,‬ﻧﻘص ﻛﺑﯾر"‪ ,‬وھذا ﯾﻣﻛن أن ﯾﺷﯾر إﻟﻰ وﺟود ﻣﺧﺎطر ﻣﺣﺗﻣﻠﺔ ﻟﻠﻣواد‬ ‫اﻟرﺋﯾﺳﯾﺔ )‪ ،(MMR‬ﻟذا ﯾرﺟﻰ ﺗﻘدﯾم ﻣﻌﻠوﻣﺎت أﻛﺛر ﺗﻔﺻﯾﻼ أدﻧﺎه ﺑﺧﺻوص ﻧﻘص اﻟﻣوظﻔﯾن‪/‬اﻟﻣﺗطوﻋﯾن اﻟﻣدرﺑﯾن‬ ‫وﻋﻣﺎ إذا ﻛﺎﻧت ھﻧﺎك ﺧطط ﻣﻌﻣول ﺑﮭﺎ ﻟﺗﺣﺳﯾن ھذا‪.‬‬ ‫‪1.6‬‬ ‫ھل ﯾﻣﻛﻧك اﻟﺗﻌﮭد ﺑﺎﻟﺧﺻوﺻﯾﺔ و اﻟﺳرﯾﺔ اﻟﻛﺎﻣﻠﺔ ﻟﻠﻣﻌﻠوﻣﺎت اﻟﻣﺎﻧﺣﺔ?‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء ﺗﻔﺎﺻﯾل( ﻻ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :2‬اﻟﻣﺗطﻠﺑﺎت اﻟﺗﻧظﯾﻣﯾﺔ اﻷﺳﺎﺳﯾﺔ‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﯾوﺻﻲ اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ )‪ (GAP‬ﺑﺄن اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ اﻟﺗﻲ ﺗﻘدم ﺑرﻧﺎﻣﺞ اﻟدم‪ ،‬ﯾﺟب ﻋﻠﯾﮭﺎ إﻧﺷﺎء ﺧدﻣﺔ ﻟﻧﻘل اﻟدم ﻣﻧﻔﺻﻠﺔ ﺑواﺳطﺔ ﻣﺟﻠس إدارة ﻣﮭﻧﻲ ﺑﻣﺳؤوﻟﯾﺔ ﻣﻔوﺿﺔ ﻋن‬ ‫اﻟﺗوﺟﯾﮫ اﻻﺳﺗراﺗﯾﺟﻲ واﻟرﻗﺎﺑﺔ ﻋﻠﻰ اﻷداء اﻟﺗﺷﻐﯾﻠﻲ‪ .‬ﻣﮭﺎرات وﻣﻌرﻓﺔ ﻣﻔﯾدة ﻟﻠﻐﺎﯾﺔ ﻷﻋﺿﺎء ﻣﺟﻠس اﻹدارة ﺗﺷﻣل اﻟﺗﻘﻧﯾﺔ اﻟﺣﯾوﯾﺔ واﻹدارة اﻟطﺑﯾﺔ‪ /‬اﻟﻌﻠﻣﯾﺔ‪ ،‬واﻻﻗﺗﺻﺎدﯾﺔ‪ /‬اﻟﻣﺎﻟﯾﺔ واﻟﺳﯾﺎﺳﯾﺔ واﻟﻘﺎﻧوﻧﯾﺔ‪.‬‬ ‫‪2.1‬‬ ‫ھل ﻟدى اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻣﺟﻠس إدارة ﻣﻧﻔﺻل ﻟﺧدﻣﺔ ﻧﻘل اﻟدم‪ ،‬ﺑﻣﺳؤوﻟﯾﺔ ﻣﻔوﺿﺔ وإﺷراف ﻋﻠﻰ اﻟﺗﺧطﯾط‬ ‫اﻻﺳﺗراﺗﯾﺟﻲ واﻹدارة اﻟﺗﻧﻔﯾذﯾﺔ واﻟﺳﻠطﺔ اﻟﻣﺎﻟﯾﺔ اﻟﻣﻔوﺿﺔ ﻋﻠﻰ ﺑرﻧﺎﻣﺞ اﻟدم؟‬ ‫‪2.1.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ھل اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻟدﯾﮭﺎ ﻧظﺎم واﺿﺢ اﻟﻣﻌﺎﻟم ﻟﻠﺗﻔوﯾض‪ ،‬وﺗوﻓﯾر اﻹﯾﺿﺎح ﺑﺷﺄن اﻟﺳﻠطﺔ‬ ‫واﻟﻣﺳﺎءﻟﺔ ﺑﯾن‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﻣﺟﺎﻟس اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ وﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫ﻣﺟﻠس وإدارة ﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪2.1.2‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﻓﮭل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﮭﺎرات واﻟﻣﻌرﻓﺔ اﻟﻼزﻣﺔ ﻟﺗﻧﻔﯾذ وإدارة اﻟﺗﻐﯾﯾر‪ ،‬واﻟﺣﻔﺎظ ﻋﻠﻰ‬ ‫اﻷدوار واﻟﻣﺳؤوﻟﯾﺎت اﻟﺻﺎرﻣﺔ وﻏﯾر ذﻟك أداء ﻣﺳؤوﻟﯾﺎﺗﮭﺎ وﻓﻘﺎ ﻟﺳؤال ‪2.1‬؟‬ ‫‪2.2‬‬ ‫ھل ھﻧﺎك ھﯾﻛل إداري ﺗﻧظﯾﻣﻲ ﻣﻧﻔﺻل ﻟﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫‪2.2.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ھل ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك ﻋﻠﻰ أﺳﺎس ﻧﻣوذج ﺗﻧظﯾﻣﻲ وطﻧﻲ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :3‬ﺣﻣﺎﯾﺔ ﺿد اﻟﻣطﺎﻟﺑﺎت ﻋن اﻷﺿرار‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪:‬‬ ‫• وﻣن اﻷﻓﺿل ﺗﻣﺎﻣﺎ أن ﯾﻛون ﻟدى اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ ﺗﻐطﯾﺔ ﺗﺄﻣﯾﻧﯾﺔ ﻷﻧﺷطﺔ ﺑرﻧﺎﻣﺞ ﻧﻘل اﻟدم‪.‬‬ ‫• ﯾﻧﺑﻐﻲ أن ﯾﻛون ﻟدى ﺧدﻣﺎت ﻧﻘل اﻟدم ﺗﻌرﯾف واﺿﺢ ﻟﻌﻼﻗﺗﮭﺎ ﻣﻊ اﻟﺣﻛوﻣﺔ ودور اﻟﺣﻛوﻣﺔ ﻓﻲ ﺣﻣﺎﯾﺔ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺿد اﻟﻣطﺎﻟﺑﺎت واﻟﺧﺳﺎﺋر‪.‬‬ ‫• ﺗﻣﺛل اﻟرﻋﺎﯾﺔ اﻟﺳﻠﯾﻣﺔ ﻟﻠﻣرﺿﻰ اﻟذﯾن ﯾﻌﺎﻧون ﻣن أﺣداث ﻣﻧﺎوﺋﺔ ﻧﺗﯾﺟﺔ ﻟﻌﻼج ﻧﻘل اﻟدم ﻗﺿﯾﺔ ھﺎﻣﺔ ﺑﺎﻟﻧﺳﺑﺔ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‪.‬‬ ‫• وﻣن اﻟﻧﺎﺣﯾﺔ اﻟﻣﺛﺎﻟﯾﺔ‪ ،‬ﯾﻧﺑﻐﻲ أن ﺗﺷﺎرك ﺧدﻣﺎت ﻧﻘل اﻟدم ﻓﻲ ﺗﺛﻘﯾف اﻟﺟﻣﮭور ﺣول اﻟﻣﺧﺎطر اﻟﻣﺣﺗﻣﻠﺔ ﻓﻲ ﻧﻘل اﻟدم‪.‬‬ ‫• ﻛﻣﺎ ﯾﺟب ﻋﻠﯾﮭﺎ اﻻﺣﺗﻔﺎظ ﺑﺄﻣن ودﻗﺔ اﻟﺳﺟﻼت‪.‬‬ ‫‪3.1‬‬ ‫ھل ﯾﺗم ﺗوﻓﯾر ﺣﻣﺎﯾﺔ ﺣﻛوﻣﯾﺔ )ﻗﺎﻧوﻧﯾﺔ‪/‬ﻣﺎﻟﯾﺔ( ﻟﺗﻘدﯾم ﺧدﻣﺎت ﻧﻘل اﻟدم و‪ /‬أو ﺑﻧوك اﻟدم واﻷﻧﺳﺟﺔ؟‬ ‫‪3.2‬‬ ‫ھل ﻗد ﺗم إﻧﺷﺎء ھﯾﻛل ﻣؤﺳﺳﻲ ﻣﻧﻔﺻل ﺑﯾن اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ وﺧدﻣﺔ ﻧﻘل اﻟدم ﻟﺗﻣﻛﯾن ﺣﻣﺎﯾﺔ أﻣوال اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻣن اﻷﺿرار‬ ‫اﻟﻣﺗﻌﻠﻘﺔ ﺑﺗﻘدﯾم ﺧدﻣﺎت اﻟدم؟‬ ‫‪3.2‬أ‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬أو ﺟزﺋﯾﺎ‪:‬‬ ‫‪3.3‬‬ ‫ھل ﺗﻌﻣل ﺧدﻣﺔ ﻧﻘل اﻟدم وﻓﻘﺎ ﻟﻠﻣﻌﺎﯾﯾر اﻟدوﻟﯾﺔ )ﻣﺛل ﻣﻧظﻣﺔ اﻟﺻﺣﺔ اﻟﻌﺎﻟﻣﯾﺔ ‪ ،WHO‬اﻟﺟﻣﻌﯾﺔ اﻷﻣرﯾﻛﯾﺔ ﻟﺑﻧوك اﻟدم ‪ ،AABB‬ﻣﺟﻠس‬ ‫أوروﺑﺎ ‪ (CoE‬ﻓﻲ ﺑراﻣﺞ اﻟدم ؟‬ ‫‪3.3.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم أو ﺟزﺋﯾﺎ‪ ,‬أي اﻟﻣﻌﺎﯾﯾر ﺗﺳﺗﺧدﻣﮭﺎ ﺧدﻣﺔ ﻧﻘل اﻟدم?‬ ‫‪3.4‬‬ ‫ﻓﻲ ﺣﺎﻟﺔ ﻋدم إﺳﺗﯾﻔﺎء ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﻌﺎﯾﯾر اﻟدوﻟﯾﺔ ﻓﻲ ﺗﻧﻔﯾذ ﺑراﻣﺞ ﻧﻘل اﻟدم‪ ،‬ھل اﻟﺳﺑب ﻣوﺛﻖ؟‬ ‫‪3.5‬‬ ‫ﻓﻲ ﺣﺎﻟﺔ ﻋدم إﺳﺗﯾﻔﺎء ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﻌﺎﯾﯾر اﻟدوﻟﯾﺔ ﻓﻲ ﺗﻧﻔﯾذ ﺑراﻣﺞ ﻧﻘل اﻟدم‪ ،‬ھل اﻟﺳﺑب ﻣﻌﺗرف ﺑﮫ وﻣﻘﺑول ﻣن ﻗﺑل اﻟﺣﻛوﻣﺔ؟‬ ‫‪3.6‬‬ ‫ھل ﺗﺟري ﺧدﻣﺔ ﻧﻘل اﻟدم ﺣﻣﻼت ﺑﮭدف زﯾﺎدة اﻟوﻋﻲ اﻟﻌﺎم‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﻻ‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫‪ .1‬ﺣﻘﯾﻘﺔ أن اﻧﻌدام اﻟﺧطر ﻏﯾر ﻣﻣﻛﻧﺔ ﻣﻊ ﻋﻼج ﻧﻘل اﻟدم؟‬ ‫‪ .2‬اﻟﺣﺎﺟﺔ إﻟﻰ ﺗﺣﻘﯾﻖ اﻟﺗوازن ﺑﯾن ﻣﺧﺎطر ﻧﻘل اﻟدم ﻣﻘﺎﺑل ﻣﺧﺎطر ﻋدم ﻧﻘل اﻟدم؟‬ ‫‪ .3‬اﻹﻧﺟﺎزات اﻟﺗﻲ ﺗﺣﻘﻘت ﻓﻲ اﻟﺗﺧﻔﯾف ﻣن اﻟﻣﺧﺎطر‪ ،‬وأي ﻣﺧﺎطر ﺑﺎﻗﯾﺔ؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 3‬ﺣﻣﺎﯾﺔ ﺿد اﻟﻣطﺎﻟﺑﺎت ﻋن اﻷﺿرار )ﻣﺗﺎﺑﻌﺔ(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪3.6.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﻛﯾف ﺗ ُﺟرى ﻏﺎﻟﺑﺎ اﻟﺣﻣﻼت?‬ ‫‪3.7‬‬ ‫ھل ﻗﺎﻣت ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺗطوﯾر اﻷﻧظﻣﺔ ﻹﺑﻼغ اﻷطﺑﺎء ﺣول اﻟﻣﺧﺎطر اﻟﻣﺣﺗﻣﻠﺔ ﻟﻠﻧﻘل؟ إذا ﻛﺎن اﻷﻣر ﻛذﻟك‪ ،‬ﻛﯾف؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻻطﻼع ﻋﻠﻰ ﻣوﻗﻌﻧﺎ‬ ‫اﻟﻛﺗﯾﺑﺎت ‪ /‬ﻣﻧﺷورات‬ ‫اﻟﺷﺑﻛﺎت اﻟﺳرﯾرﯾﺔ ﻏﯾر اﻟرﺳﻣﯾﺔ‬ ‫اﻻﺟﺗﻣﺎﻋﺎت اﻟﻣﺣﻠﯾﺔ‬ ‫اﻟﻣﺷﺎرﻛﺔ ﻓﻲ ﻟﺟﺎن اﻟﻧﻘل ﺑﺎﻟﻣﺳﺗﺷﻔﻰ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪3.8‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﺳﯾﺎﺳﺔ ﻟﻼﺣﺗﻔﺎظ ﺑﺳﺟﻼت اﻟﻣﺗﺑرﻋﯾن واﻟﺗﺑرع؟‬ ‫‪3.9‬‬ ‫ھل ﺗﺣﺗﻔظ ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺗﻐطﯾﺔ ﺗﺄﻣﯾﻧﯾﺔ ﺿد اﻟﺣوادث اﻟﺗﺎﻟﯾﺔ اﻟﻣﺣﺗﻣﻠﺔ؟‬ ‫‪3.10‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ھل اﻟﺗﻐطﯾﺔ اﻟﺗﺄﻣﯾﻧﯾﺔ ﻛﺎﻓﯾﺔ؟‬ ‫‪3.11‬‬ ‫ھل ﺗﺗﻠﻘﻰ ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﺷورة اﻟﻣﮭﻧﯾﺔ ﺑﺧﺻوص ﻣﺳﺗوﯾﺎت وﻧوع اﻟﺗﻐطﯾﺔ اﻟﺗﺄﻣﯾﻧﯾﺔ؟‬ ‫‪3.12‬‬ ‫ھل ﺗﻧﻌم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺄي ﺣﻣﺎﯾﺔ إﻣﺎ ﺗﺟﺎرﯾﺔ أو ﺗﻌوﯾض ﻣن اﻟﺣﻛوﻣﺔ ﻣن اﺣﺗﻣﺎل ﺣدوث أﻣراض ﻣﻧﻘوﻟﺔ ﻋن طرﯾﻖ اﻟدم؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﺧﺳﺎﺋر ﻓﻲ اﻟﻣﻣﺗﻠﻛﺎت‬ ‫اﻟﻣﺳؤوﻟﯾﺔ اﻟﻌﺎﻣﺔ‬ ‫ﻣﺳؤوﻟﯾﺔ اﻟﻘﺎﻧوﻧﯾﺔ ﻋن أﺿرار اﻟدم وﻣﻧﺗﺟﺎﺗﮫ‬ ‫ﻣﺳؤوﻟﯾﺔ اﻟﻣدﯾرﯾن واﻟﻣوظﻔﯾن‬ ‫اﻟﺗﻌوﯾض اﻟﻣﮭﻧﻲ‬ ‫اﻻﺣﺗﯾﺎل اﻟداﺧﻠﻲ‬ ‫إﺻﺎﺑﺔ اﻟﻣﺗﺑرع‬ ‫اﻟﺗﻼﻋب اﻟﺧﺑﯾث ﺑﺎﻟﻣﻧﺗﺞ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‪ ،‬ﻋﻠﻰ‬ ‫اﻷﻗل ﺳﻧوﯾﺎ‬ ‫ﻧﻌم‪ ،‬دورﯾﺎ‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫‪‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :4‬اﻟدﻋم ﻟﻠﻣﺗﻠﻘﯾن ﻟﻠدم اﻟﻣﻠوث‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﯾﺟب ﻋﻠﻰ ﺟﻣﻌﯾﺎت اﻟﮭﻼل اﻷﺣﻣر‪ /‬اﻟﺻﻠﯾب اﻷﺣﻣر إظﮭﺎر اﻟﺗﻌﺎطف ﻣﻊ ﺟﻣﯾﻊ اﻟﻣﺗﻠﻘﯾن ﻟﻠدم اﻟﻣﻠوث‪ .‬ﻻ ﯾﻣﻛن ﻟﺧدﻣﺔ ﻧﻘل اﻟدم أن ﺗﺗﺣﻣل ﻣﺳؤوﻟﯾﺔ ﺧطر اﻟﻌدوى‬ ‫اﻟﻛﺎﻣن ﻓﻲ ﻣﻧﺗﺟﺎت اﻟدم‪ .‬وﻣﻊ ذﻟك‪ ،‬ﻓﺈﻧﮫ ﻣن اﻟﻣﻧﺎﺳب ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻟﺧدﻣﺎت ﻧﻘل اﻟدم ﺗوﻓﯾر اﻟدﻋم ﻟﻣﺗﻠﻘﻲ ﻧﻘل اﻟدم اﻟﻣﺻﺎب‪ .‬وھذا ﻗد ﯾﺷﻣل اﻟدﻋم اﻟﻣﺎﻟﻲ واﻟﻧﻔﺳﻲ واﻟطﺑﻲ‬ ‫واﻻﺟﺗﻣﺎﻋﻲ‪.‬‬ ‫‪ 4.1‬ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم اﻟدﻋم ﻟﻠﻣﺗﻠﻘﯾن ﻟﻠدم اﻟﻣﻠوث؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 4.1.1‬إذا ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ﻣﺎ اﻟوﻛﺎﻻت اﻟﺗﻲ ﺗﻘدم اﻟدﻋم ﻟﻠﻣﺗﻠﻘﯾن?‬ ‫‪4.2‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم ﺗﻌوﯾﺿﺎت ﻣﺎﻟﯾﺔ ﻟﻣﺗﻠﻘﻲ اﻟدم اﻟﻣﻠوث؟‬ ‫‪4.3‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم اﻟدﻋم اﻟﻧﻔﺳﻲ اﻟﻣﮭﻧﻲ ﻟﻣﺗﻠﻘﻲ اﻟدم اﻟﻣﻠوث؟‬ ‫‪4.4‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم اﻟدﻋم اﻟطﺑﻲ ﻟﻣﺗﻠﻘﻲ اﻟدم اﻟﻣﻠوث؟‬ ‫‪4.5‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أو وزارة اﻟﺻﺣﺔ آﻟﯾﺔ ﻟﺗﻘدﯾم اﻟدﻋم اﻻﺟﺗﻣﺎﻋﻲ ﻟﻣﺗﻠﻘﻲ اﻟدم اﻟﻣﻠوث؟‬ ‫ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل اﻟدﻋم ﻓﻲ ﻣﺣﺎدﺛﺎت اﻟﺗﺄﻣﯾن اﻟﺻﺣﻲ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :5‬اﻟﺳﻼﻣﺔ ﻣﻘﺎﺑل اﻟﺗﻛﻠﻔﺔ‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪:‬‬ ‫• ﺗﺗﻧﺎول ھذه اﻷﺳﺋﻠﺔ اﻟﻣﺳﺎﺋل اﻟﻣﺗﻌﻠﻘﺔ ﺑﺎﻟﺗوازن ﺑﯾن اﻟﺳﻼﻣﺔ واﻟﺗﻛﻠﻔﺔ واﻟﺗواﻓر‪.‬‬ ‫• ﻋﻠﻰ اﻟرﻏم ﻣن وﺟود ﺧطوة ﻣﺳﺗﻣرة ﻧﺣو ﺗﺣﺳﯾن ﺳﻼﻣﺔ ﻣﻧﺗﺟﺎت اﻟدم‪ ،‬إﻻ أﻧﮫ ﻣن اﻟﻣﮭم اﻟﺗﺄﻛد ﻣن أن اﻟﺧطر اﻟﺻﻐﯾر اﻟﻣﻌروف ﻻ ﯾﺗم اﺳﺗﺑداﻟﮫ ﺑﺧطر أﻛﺑر ﻣﺟﮭول ﻣﺣﺗﻣل اﻟﺣدوث‪ .‬أﯾﺿﺎ‪،‬‬ ‫ﯾﻣﻛن أن ﯾﻛون ﻟدى اﻟﺟﮭود اﻟﻣﺑذوﻟﺔ ﻟزﯾﺎدة اﻟﺳﻼﻣﺔ ﺗﺄﺛﯾرا ﻋﻠﻰ ﺗواﻓر ﻣﻧﺗﺟﺎت اﻟدم ﺑﺷﻛل ﻋﺎم‪.‬‬ ‫• إن ﻟﻠوﻋﻲ اﻟﻣﺳﺗﻣر ﺑﺎﻟﺗﮭدﯾدات اﻟﻧﺎﺷﺋﺔ‪ ،‬وﺗﺛﻘﯾف اﻟوﻛﺎﻻت اﻟﺣﻛوﻣﯾﺔ ﺣول ﺗداﺑﯾر اﻟﺳﻼﻣﺔ اﻟﺟدﯾدة دورا ھﺎﻣﺎ ﻓﻲ ﺧدﻣﺔ ﻧﻘل اﻟدم‪.‬‬ ‫• ﻛﻣﺎ أن آﻟﯾﺎت ﻣراﺟﻌﺔ اﻟﻣﺎﺿﻲ ﻟﺗﻌﻘب اﺳﺗﺧدام اﻟﻣﻧﺗﺞ واﻟﺗﺄﻛد ﻣن أن ﻣﻛوﻧﺎت اﻟدم ﺗﺳﺗﺧدم ﺑﺷﻛل ﻣﻧﺎﺳب داﺧل اﻟﻣﺳﺗﺷﻔﯾﺎت ﻣﺛﺎر ﻗﻠﻖ ﺑﺎﻟﻎ‪.‬‬ ‫‪5.1‬‬ ‫ھل ﺗﻘوم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺈﺟراء ﺗﺣﻠﯾل ﻟﻠﺗﻛﻠﻔﺔ‪ /‬اﻟﻣﻧﻔﻌﺔ ﻟﺟﻣﯾﻊ اﻟﻣﻘﺗرﺣﺎت اﻟﺟدﯾدة ﻟﺗﻌزﯾز اﻟﺳﻼﻣﺔ؟‬ ‫‪5.2‬‬ ‫ھل ﺗﻘوم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺈﺷراك اﻟوﻛﺎﻻت اﻟﺣﻛوﻣﯾﺔ ﺑﺷﻛل ﻓﻌﺎل ﻓﻲ أھﻣﯾﺔ اﻟﺗﻣوﯾل اﻟﻛﺎﻓﻲ ﻟﻠﻣﺑﺎدرات‬ ‫اﻟﺟدﯾدة ﻟﺳﻼﻣﺔ اﻟدم وﻋواﻗب ﻋدم ﺗﻣوﯾﻠﮭﺎ؟‬ ‫‪5.3‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أﻧظﻣﺔ ﻣطﺑﻘﺔ ﻟرﺻد اﻟﺗﮭدﯾدات اﻟﻧﺎﺷﺋﺔ ﻟﺳﻼﻣﺔ إﻣدادات اﻟدم )ﻣﺛل ﻣراﻗﺑﺔ اﻷﻣراض‬ ‫اﻹﻗﻠﯾﻣﯾﺔ(؟‬ ‫‪5.4‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم أﻧظﻣﺔ ﻣطﺑﻘﺔ ﻟﺿﻣﺎن اﺳﺗﯾﻔﺎء اﻟﺟواﻧب اﻷرﺑﻌﺔ اﻟﺗﺎﻟﯾﺔ ﻟﺳﻼﻣﺔ ﻧﻘل اﻟدم )ﻟﺿﻣﺎن‬ ‫ﻧﺗﺎﺋﺞ أﻓﺿل ﻟﻠﻣرﺿﻰ(‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﯾﺗم ﺗوﻓﯾر ﻧوع اﻟدم اﻟﺻﺣﯾﺢ‪.‬‬ ‫ﯾﺗم إﻋطﺎء اﻟﻣﻧﺗﺞ إﻟﻰ اﻟﻣرﯾض اﻟﺻﺣﯾﺢ‪.‬‬ ‫ﯾﺗم إﻋطﺎء اﻟﻣﻧﺗﺞ ﻓﻲ اﻟوﻗت اﻟﺻﺣﯾﺢ‪.‬‬ ‫اﻵﻟﯾﺔ اﻟﻣدﻣﺟﺔ اﻟﺻﺣﯾﺣﺔ ﻟﻣراﺟﻌﺔ اﻟﻣﺎﺿﻲ‪.‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :5‬اﻟﺳﻼﻣﺔ ﻣﻘﺎﺑل اﻟﺗﻛﻠﻔﺔ )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪ 5.5‬ھل ﺗﺳﻌﻰ ﺧدﻣﺔ ﻧﻘل اﻟدم إﻟﻰ اﻟﺗﺣﻛم ﻓﻲ اﻻﺳﺗﺧدام اﻟﻣﻧﺎﺳب ﻟﻠﻣﻧﺗﺞ‪ ،‬واﻟﺗﺧزﯾن‪ /‬اﻟﻣﻌﺎﻟﺟﺔ‪ ،‬واﻟﺣد اﻷدﻧﻰ ﻣن‬ ‫اﻟﮭدر وﻣﺎ إﻟﻰ ذﻟك؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪5.5.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪,‬‬ ‫ﻛﯾف ?‬ ‫ﯾرﺟﻰ اﻟﺗﺣدﯾد‪:‬‬ ‫اﻟﻧﺳﺑﺔ اﻟﻣﺋوﯾﺔ ﻟﻠﻣﺳﺗﺧدﻣﯾن اﻟﻧﮭﺎﺋﯾﯾن ﺣﯾث ﯾوﺟد اﺗﻔﺎق ﻣطﺑﻖ ﻣﻛﺗوب؟‬ ‫‪5.6‬‬ ‫ھل ﻟدى اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﺗﻲ ﺗﺳﺗﺧدم ﻣﻧﺗﺟﺎت اﻟدم ﻣن ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك ﻟﺟﻧﺔ ﻧﻘل ﻓﻌﺎﻟﺔ ﻣﺗﻌددة‬ ‫اﻟﺗﺧﺻﺻﺎت?‬ ‫ﻧﻌم‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﻌﺎﻣﺔ‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﺧﺎﺻﺔ‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت ﻏﯾر اﻟﮭﺎدﻓﺔ ﻟﻠرﺑﺢ‬ ‫اﻟﻌﯾﺎدات‬ ‫اﻟﻘوات اﻟﻣﺳﻠﺣﺔ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪5.6‬أ‬ ‫ﻣﺎ اﻟﻧﺳﺑﺔ اﻟﻣﺋوﯾﺔ ﻣن اﻹﺟﻣﺎﻟﻰ اﻟوطﻧﻰ اﻟﺗﻲ ﺗﻣﺛل ھؤﻻء اﻟﻣﺳﺗﺧدﻣﯾن‪:‬‬ ‫‪5.6.1‬‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم أو ﺟزﺋﯾﺎ‪ ,‬ھل ﺗﺷﺎرك ﺧدﻣﺔ ﻧﻘل اﻟدم ﻓﻲ‬ ‫اﻟﻠﺟﺎن؟‬ ‫‪5.7‬‬ ‫ھل ﺗﺷﺎرك ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﻊ اﻟﺳﻠطﺎت اﻟﺻﺣﯾﺔ اﻟﻣﺧﺗﺻﺔ ﻓﻲ ﺗطوﯾر اﻟﻣﻌﺎﯾﯾر اﻟوطﻧﯾﺔ؟‬ ‫‪5.8‬‬ ‫ﺗﻘرﯾﺑﺎ ﻣﺎ ھﻲ اﻟﻧﺳﺑﺔ اﻟﻣﺋوﯾﺔ ﻹﻣدادات اﻟدم اﻟﺧﺎﺻﺔ ﺑك اﻟﺗﻲ ﺗﺄﺗﻲ ﻣن ﻣﺎﻧﺣﻲ اﻟﺗﺑرع ﺑﺎﻟدم طوﻋﺎ وﺑدون‬ ‫ﻣﻘﺎﺑل )‪(VNRBD‬؟‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﻌﺎﻣﺔ‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت اﻟﺧﺎﺻﺔ‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت ﻏﯾر اﻟﮭﺎدﻓﺔ ﻟﻠرﺑﺢ‬ ‫اﻟﻌﯾﺎدات‬ ‫اﻟﻘوات اﻟﻣﺳﻠﺣﺔ‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫ﻧﻌم‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪%‬‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :5‬اﻟﺳﻼﻣﺔ ﻣﻘﺎﺑل اﻟﺗﻛﻠﻔﺔ )ﻣﺗﺎﺑﻌﺔ(‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :6‬اﻟﺗﻣوﯾل‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﯾﺟب أن ﺗﻛون اﻻﺳﺗﻌدادات اﻟﻣﺎﻟﯾﺔ اﻟﻛﺎﻓﯾﺔ وطوﯾﻠﺔ اﻷﺟل ﻣطﺑﻘﺔ وﯾﺗم ﻣراﺟﻌﺗﮭﺎ ﻣن ﻗﺑل ﺟﻣﻌﯾﺔ اﻟﺻﻠﯾب اﻷﺣﻣر‪ /‬اﻟﮭﻼل اﻷﺣﻣر اﻟﻣﺣﻠﯾﺔ ﻗﺑل اﻟﺑدء أو اﻟﺑﻘﺎء ﻓﻲ أي ﺑرﻧﺎﻣﺞ‬ ‫ﻧﻘل ﻟﻠدم‪ .‬إن أﻓﺿل ﺗﺄﻣﯾن ﻟﻠﺗﻣوﯾل اﻟﻣﺳﺗدام ﻣن ﺧﻼل إﻣﺎ اﺳﺗرداد اﻟﺗﻛﺎﻟﯾف أو اﻟﺗﻣوﯾل اﻟﺣﻛوﻣﻲ‪ ،‬ﻋﻠﻰ اﻟرﻏم ﻣن أن اﺳﺗﺧدام ﺑﻌض اﻟﻣﻧﺎطﻖ ﻟﻠﺗﺑرﻋﺎت اﻟﻌﺎﻣﺔ ﻣن ﺷﺄﻧﮫ أن ﯾدﻋم‪ .‬ﯾﺟب أن ﯾﻛون‬ ‫ﺗﺣوﯾل اﻷﻣوال ﺑﯾن اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ وﺧدﻣﺎت ﻧﻘل اﻟدم ﻓﻲ ﺳﯾﺎق اﻻﺗﻔﺎﻗﺎت اﻟﻣﻧﺎﺳﺑﺔ ﻋﻠﻰ ﻣﺳﺗوى اﻟﺧدﻣﺔ‪ .‬ﯾﻧظر إﻟﻰ اﻻﺳﺗﻌدادات اﻟﻣﺎﻟﯾﺔ اﻟﺷﻔﺎﻓﺔ واﻟﻣﺳﺗداﻣﺔ ﺿﻣن ﺧدﻣﺎت ﻧﻘل اﻟدم وﺑﯾن ﺧدﻣﺔ‬ ‫ﻧﻘل اﻟدم وﺟﻣﻌﯾﺔ اﻟﺻﻠﯾب اﻷﺣﻣر‪ /‬اﻟﮭﻼل اﻷﺣﻣر ﻛﺄوﻟوﯾﺔ‪.‬‬ ‫‪ 6.1‬ﻣﺎ ھﻲ اﻟﻧﺳﺑﺔ اﻟﻣﺋوﯾﺔ ﻹﺟﻣﺎﻟﻲ ﻣﯾزاﻧﯾﺔ ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك اﻟﺗﻲ ﺗﺄﺗﻲ ﻣن‪:‬‬ ‫‪6.1.1‬‬ ‫اﻟﺣﻛوﻣﺔ‬ ‫‪6.1.2‬‬ ‫اﻟﻣﺳﺗﺷﻔﯾﺎت‬ ‫‪6.1.3‬‬ ‫ﺗﻛﻠﻔﺔ رﺳوم اﻻﺳﺗرداد ﻟﻠﻣﺳﺗﺧدﻣﯾن اﻟﻧﮭﺎﺋﯾﯾن‬ ‫‪6.1.4‬‬ ‫أﻧﺷطﺔ اﻟﺗﻣوﯾل اﻟداﺧﻠﯾﺔ‬ ‫‪6.1.5‬‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺧﺎﺻﺔ ﺑك‬ ‫‪6.1.6‬‬ ‫اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ اﻷﺧرى‬ ‫‪6.1.7‬‬ ‫‪) NGOs‬اﻟﻣﻧظﻣﺎت ﻏﯾر اﻟﺣﻛوﻣﯾﺔ( واﻟﺻﻧﺎدﯾﻖ اﻟدوﻟﯾﺔ‬ ‫‪6.1.8‬‬ ‫ﻧظﺎم اﻟﺗﺄﻣﯾن اﻟﺻﺣﻲ اﻟﻌﺎم واﻟﺧﺎص‬ ‫‪6.1.9‬‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك(‪:‬‬ ‫‪:‬‬ ‫‪6.2‬‬ ‫اﻟﻣوردﯾن ﻟﯾس ﻟدﯾﮭم أي أﺳﮭم ﻋﺎدﯾﺔ أو رﻗﺎﺑﺔ‬ ‫ھل ﺗﺿﻣن ﺧدﻣﺔ ﻧﻘل اﻟدم أن اﻟﻣﻧظﻣﺎت "اﻟرﺑﺣﯾﺔ" أو‬ ‫إدارﯾﺔ ﻓﻲ ﺑرﻧﺎﻣﺞ ﻧﻘل اﻟدم؟‬ ‫ﯾرﺟﻰ إﻋطﺎء‪ ٪‬ﻟﻛل ﻣﻧﮭﺎ‪:‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫‪%‬‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫ﻧﻌم‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪6.3‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﺳﯾﺎﺳﺔ ﻟﺿﻣﺎن ﻋدم وﺟود ﺗﺿﺎرب ﻓﻲ اﻟﻣﺻﺎﻟﺢ ﻟـ‪:‬‬ ‫‪6.4‬‬ ‫ھل ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم ﺳﯾﺎﺳﺔ ﻟﺿﻣﺎن ﻋدم وﺟود ﺗﺿﺎرب ﻓﻲ اﻟﻣﺻﺎﻟﺢ ﻋﻧد اﻟﺗﻌﺎﻣل ﻣﻊ اﻟﻣوردﯾن‬ ‫اﻟرﺋﯾﺳﯾﯾن؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫أﻋﺿﺎء ﻣﺟﻠس اﻹدارة‬ ‫ﻛﺑﺎر اﻟﻣوظﻔﯾن‬ ‫اﻟﻣﺗطوﻋون‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :6‬اﻟﺗﻣوﯾل )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪6.5‬‬ ‫ھل ھﻧﺎك اﺗﻔﺎق رﺳﻣﻲ ﻣطﺑﻖ ﻹدارة وﺻول اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻟﺻﻧﺎدﯾﻖ ﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫‪6.6‬‬ ‫ھل ﺗم ﻓرض ﺣﺟرا ﺻﺣﯾﺎ ﻋﻠﻰ اﺳﺗﺧدام ﺻﻧﺎدﯾﻖ ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣن ﻗﺑل ﺧدﻣﺎت ﻧﻘل اﻟدم؟‬ ‫‪6.7‬‬ ‫ھل ﺗﻘدم اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟدﻋم اﻟﻣﺎﻟﻲ ﻟﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫‪6.8‬‬ ‫ھل ﺗﺳﺎھم اﻟﺻﻧﺎدﯾﻖ ﻣن ﺧدﻣﺔ ﻧﻘل اﻟدم ﻓﻲ أﻧﺷطﺔ ﻟﻠﺻﻠﯾب اﻷﺣﻣر ﻏﯾر ﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫ﻧﻌم ‪ -‬ﻻ ﯾﻣﻛن ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟوﺻول إﻟﻰ اﻟﺻﻧﺎدﯾﻖ‬ ‫ﻧﻌم ‪ -‬ﯾﺳﻣﺢ اﻻﺗﻔﺎق اﻟرﺳﻣﻲ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺑﺎﻟوﺻول إﻟﻰ‬ ‫اﻟﺻﻧﺎدﯾﻖ ﻋﻧد اﻟﻠزوم‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻏﯾر ذﻟك ‪) :‬ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل أدﻧﺎه(‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :6‬اﻟﺗﻣوﯾل )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪6.9‬‬ ‫ھل ھﻧﺎك ﻧظم ﻣﺣﺎﺳﺑﯾﺔ ﻣﻧﻔﺻﻠﺔ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ وﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :7‬اﻟﻣﻌرﻓﺔ ﺑﺷﺄن ﻣﺧﺎطر اﻟدم وﻋواﻗﺑﮫ‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﻣن اﻟﻣﮭم أن ﺗﻘدم ﺧدﻣﺎت ﻧﻘل اﻟدم اﻟﺗﺎﺑﻌﺔ ﻟﺟﻣﻌﯾﺔ اﻟﺻﻠﯾب اﻷﺣﻣر‪ /‬اﻟﮭﻼل اﻷﺣﻣر اﻟﺗﻌﻠﯾم اﻟﻣﻧﺎﺳب ﻟﻛل ﻣن ﻋﻣوم اﻟﻧﺎس وﻏﯾرھم ﻣن اﻟﺷرﻛﺎء ﻣﺛل اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫واﻟﺣﻛوﻣﺔ واﻟﻛﻠﯾﺎت اﻟطﺑﯾﺔ وﻣوظﻔﻲ ﺧدﻣﺎت ﻧﻘل اﻟدم ﻣن أﺟل ﻧﻘل ﻓﮭم أﻓﺿل ﻟﻠﻣﺧﺎطر اﻟﻛﺎﻣﻧﺔ ﻓﻲ ﻧﻘل اﻟدم‪.‬‬ ‫‪7.1‬‬ ‫ھل ﯾﺟب ﻋﻠﻰ اﻟﻣرﺿﻰ ﺗﻘدﯾم ﻣواﻓﻘﺔ ﻣﺳﺑﻘﺔ ﺧطﯾﺔ ﻋن ﻋﻠم ﻗﺑل ﻧﻘل اﻟدم؟‬ ‫‪7.1.1‬‬ ‫ھل ﺗﻌﻣل ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﻊ اﻟﻣﺳﺗﺷﻔﯾﺎت ﻟﺿﻣﺎن وﺟود ﺳﯾﺎﺳﺔ أو إﺟراءات ﻣﻧﻔذة ﺗطﻠب ﻣن اﻟﻣرﺿﻰ‬ ‫ﺗﻘدﯾم ﻣواﻓﻘﺔ ﺧطﯾﺔ ﻋن ﻋﻠم ﻗﺑل اﻟﻧﻘل؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻗﺎﺑﻠﺔ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﻟﻠﺗطﺑﯾﻖ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 7.2‬ھل ﻗﺎﻣت ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺗطوﯾر وﺗﻧﻔﯾذ اﺳﺗراﺗﯾﺟﯾﺎت ﺗﮭدف إﻟﻰ ﺗﺣﺳﯾن اﻟﺗﻌﻠﯾم اﻟﻌﺎم ﻓﯾﻣﺎ ﯾﺗﻌﻠﻖ ﺑﺳﻼﻣﺔ‬ ‫إﻣدادات اﻟدم ﻣن ﻣﺧﺎطر ﻧﻘل اﻟدم؟‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪:‬‬ ‫‪7.2.1‬‬ ‫ﻧﻌم‬ ‫اﻟﺑراﻣﺞ اﻟﻣدرﺳﯾﺔ‬ ‫وﺳﺎﺋل اﻹﻋﻼم )ﺑﻣﺎ ﻓﻲ ذﻟك وﺳﺎﺋل اﻟﺗواﺻل اﻻﺟﺗﻣﺎﻋﻲ(‬ ‫اﻻطﻼع ﻋﻠﻰ ﻣوﻗﻌﻧﺎ‬ ‫اﻟﻛﺗﯾﺑﺎت ‪ /‬ﻣﻧﺷورات‬ ‫اﻟﺷﺑﻛﺎت ﻏﯾر اﻟرﺳﻣﯾﺔ‬ ‫ﺗﻌﻠﯾم اﻟﻣﺗﺑرﻋﯾن‬ ‫وﺿﻊ اﻟﻣﻣﺛﻠﯾن ﻓﻲ ھﯾﺋﺎت ﻣﻧﺎﺳﺑﺔ ﻟﺻﻧﻊ اﻟﻘرار‬ ‫‪:‬‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ھل اﻻﺳﺗراﺗﯾﺟﯾﺎت اﻟﻣذﻛورة أﻋﻼه ﺗم ﺗﻧﻔﯾذھﺎ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :7‬اﻟﻣﻌرﻓﺔ ﺑﺷﺄن ﻣﺧﺎطر اﻟدم وﻋواﻗﺑﮫ )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪7.3‬‬ ‫ھل ﺗوﻓر ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺗﻌﻠﯾم ﺑﺷﺄن ﻣﺧﺎطر ﻧﻘل اﻟدم إﻟﻰ ﻏﯾرھﺎ ﻣن اﻟﺟﮭﺎت اﻟﻣﻌﻧﯾﺔ‪ ،‬ﺑﻣﺎ ﻓﻲ ذﻟك‪:‬‬ ‫ﻧﻌم‬ ‫اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﺣﻛوﻣﺔ‬ ‫اﻟﻛﻠﯾﺎت اﻟطﺑﯾﺔ‬ ‫ﻣوظﻔﻲ ﺧدﻣﺔ ﻧﻘل اﻟدم‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ اﻟﺗﺣدﯾد(‪:‬‬ ‫‪7.4‬‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫‪:‬‬ ‫ھل ﺗﻘوم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺈﺟراء ﺣﻣﻼت ﻣﻧﺗظﻣﺔ ﻟﺗﺛﻘﯾف اﻟﺟﻣﮭور ﺑﺷﺄن اﻟﺣﺎﺟﺔ إﻟﻰ اﻟﺗﺑرع ﺑﺎﻟدم ﺑﺎﻧﺗظﺎم؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم )ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :8‬اﻟﻣﮭﺎرات اﻹدارﯾﺔ‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪ :‬ﻣن أﺟل ﺗﺣﻘﯾﻖ واﻟﻣﺣﺎﻓظﺔ ﻋﻠﻰ ﻣﺳﺗوى ﺟﯾد ﻟﻺدارة ﻓﻲ ﺧدﻣﺎت ﻧﻘل اﻟدم اﻟﺗﺎﺑﻌﺔ ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‪ ،‬ﯾﺟب أن ﯾﻛون ھﻧﺎك رؤﯾﺔ واﺿﺣﺔ ﻣﺑﯾﻧﺔ ورﺳﺎﻟﺔ وﺧطﺔ اﺳﺗراﺗﯾﺟﯾﺔ‬ ‫وأھداف اﺳﺗراﺗﯾﺟﯾﺔ ﻣﻊ وﺳﯾﻠﺔ ﻟﻘﯾﺎس اﻟﺗﻘدم اﻟﻣﺣرز ﻧﺣو ﺗﺣﻘﯾﻖ ھذه اﻷھداف‪.‬‬ ‫‪8.1‬‬ ‫ھل ﻣﺎ ﯾﻠﻲ ﻣطﺑﻖ ﻟدى ﺧدﻣﺔ ﻧﻘل اﻟدم؟‬ ‫‪8.2‬‬ ‫إذا ﻛﺎن ذﻟك ﻣطﺑﻘﺎ‪ ،‬ھل ﺗﻘوم اﻷھداف اﻻﺳﺗراﺗﯾﺟﯾﺔ ﻟﺧدﻣﺔ ﻧﻘل اﻟدم ﺑـ‪:‬‬ ‫ﻧﻌم‬ ‫رؤﯾﺔ واﺿﺣﺔ‬ ‫ﻣﮭﻣﺔ واﺿﺣﺔ‬ ‫ﺧطﺔ اﺳﺗراﺗﯾﺟﯾﺔ‬ ‫أھداف اﺳﺗراﺗﯾﺟﯾﺔ‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺗﺣدﯾد اﻟﻣﺳؤوﻟﯾﺔ اﻟواﺿﺣﺔ‬ ‫ﻣﻌﺎﻟﺟﺔ اﺣﺗﯾﺎﺟﺎت اﻟﻣﺗﺑرع‬ ‫ﻣﻌﺎﻟﺟﺔ اﺣﺗﯾﺎﺟﺎت اﻟﻣﺗﻠﻘﻲ‬ ‫ﻣﻌﺎﻟﺟﺔ اﺣﺗﯾﺎﺟﺎت اﻟطﺑﯾب‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 8.3‬ھل ﻗد ﺗم إﻧﺷﺎء وﺗﻧﻔﯾذ أھداف اﻷداء اﻟرﺋﯾﺳﯾﺔ )ﻣﺛل اﻧﺧﻔﺎض‪ ٪‬ﻓﻲ اﻟوﻗت اﻟﻣﺣﺗﺳب ﺑدل اﻟﺿﺎﺋﻊ‬ ‫ﻟﻠﻣوظﻔﯾن‪ ،‬واﻧﺧﻔﺎض ‪ ٪‬ﻓﻲ ﻓﻘد اﻟﻣﻧﺗﺞ(؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :8‬اﻟﻣﮭﺎرات اﻹدارﯾﺔ )ﻣﺗﺎﺑﻌﺔ(‬ ‫‪8.4‬‬ ‫ھل ﺑراﻣﺞ اﻟﺗدرﯾب ﻣطﺑﻘﺔ ﻟﺣﻔظ وﺗطوﯾر اﻟﻣﮭﺎرات اﻹدارﯾﺔ واﻟﻘﯾﺎدﯾﺔ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :9‬اﻟﺗﻘﺳﯾم‬ ‫ﻣﻼﺣظﺔ ﺗوﺿﯾﺣﯾﺔ‪:‬‬ ‫• ﻓﻲ اﻟﺑﻠدان اﻟﻣﺗﻘدﻣﺔ‪ ،‬ﻓﺈﻧﮫ ﻟﯾس ﻣن اﻟﻣرﻏوب ﻓﯾﮫ ﻟﻠﺻﻠﯾب اﻷﺣﻣر ‪ /‬اﻟﮭﻼل اﻷﺣﻣر ﺑدء أﻧﺷطﺔ ﺗﺟزﺋﺔ ﺑﺳﺑب ﺧطر اﻟﮭدر اﻟﮭﺎﺋل‪ ،‬إﻻ إذا ﻛﺎن ﻧطﺎق اﻟﻌﻣﻠﯾﺎت ﻓﻲ ذﻟك اﻟﺑﻠد ﯾﺟﻌﻠﮭﺎ ﻗﺎﺑﻠﺔ ﻟﻠﺗطﺑﯾﻖ‪.‬‬ ‫• ﻓﻲ اﻟﺑﻠدان اﻟﻧﺎﻣﯾﺔ ﯾﺟوز ﻟﻠﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﻧظر ﻓﻲ اﻟﺗﺟزﺋﺔ إذا ﻛﺎن ھذا ھو اﻟﺳﺑﯾل اﻟوﺣﯾد ﻟﻣﺻدر اﻟﻣﻧﺗﺟﺎت اﻟﻣﺷﺗﻘﺔ ﻣن اﻟﺑﻼزﻣﺎ‪ ،‬وﻟﻛن ﻓﻘط إذا ﺗم ﺗﺄﻣﯾن اﻟدﻋم واﻟﺳﻠطﺔ اﻟﺣﻛوﻣﯾﺔ اﻟﻣﻧﺎﺳﺑﺔ‪.‬‬ ‫• إذا ﻛﺎن ﻟﯾﺗم اﻟﺗﺧﻠص ﻣن اﻟﺑﻼزﻣﺎ‪ ،‬ﯾﻧﺑﻐﻲ ﻧﺻﺢ اﻟﻣﺗﺑرﻋﯾن‪.‬‬ ‫• ﻗﺑل أن ﺗﻘوم اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ إﻣﺎ ﺑﺎﻟﺗﺟزﺋﺔ أو اﻻﺳﺗﻌﺎﻧﺔ ﺑﻣﺻﺎدر ﺧﺎرﺟﯾﺔ ﻟﻠﻣﺟزﺋﺎت أﺧرى‪ ،‬ﯾﺟب ﻋﻠﻰ اﻟﺳﻠطﺎت اﻟﺣﻛوﻣﯾﺔ اﻟﻣﺧﺗﺻﺔ اﻟﻣواﻓﻘﺔ ﻋﻠﻰ ﺗﺻﻧﯾﻊ اﻟﻣﻧﺗﺟﺎت وﻋﻣﻠﯾﺎت اﻟﺗﺳوﯾﻖ‪.‬‬ ‫• ﻣوﻗف ﺟﻣﻌﯾﺎت اﻟﺻﻠﯾب اﻷﺣﻣر واﻟﮭﻼل اﻷﺣﻣر ‪ IFRC‬ھو أن اﻻﻛﺗﻔﺎء اﻟذاﺗﻲ اﻟوطﻧﻲ ﻣﺳﺄﻟﺔ ﺗﺧص ﺳﯾﺎﺳﺔ اﻟﺣﻛوﻣﺔ ﻓﻲ ھذا اﻟﺑﻠد‪.‬‬ ‫‪9.1‬‬ ‫ھل ﻟدى اﻟﺣﻛوﻣﺔ ﺳﯾﺎﺳﺔ اﻻﻛﺗﻔﺎء اﻟذاﺗﻲ اﻟوطﻧﻲ ﻟﻣﻧﺗﺟﺎت اﻟدم اﻟﺗﻲ ﺗﺷﻣل ﻣﻧﺗﺟﺎت اﻟﺑﻼزﻣﺎ؟‬ ‫‪9.2‬‬ ‫ھل ﺗﻘوم ﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺗﺷﻐﯾل واﺣد أو أﻛﺛر ﻣن ﻣﺣطﺔ ﺗﺟزﺋﺔ؟‬ ‫‪9.2.1‬‬ ‫ھل ﻟدى ﺧطﺔ ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ أي ﺗدﺧل ﻓﻲ ﺗﺷﻐﯾل ﻣﺣطﺎت اﻟﺗﺟزﺋﺔ ﻓﻲ اﻟﻣﺳﺗﻘﺑل اﻟﻘرﯾب؟‬ ‫‪9.3‬‬ ‫ھل ﺗرﺳل ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ إﻟﻰ ﻣﺟزئ ﺧﺎرﺟﻲ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ :9‬ﻣﺗﺎﺑﻌﺔ اﻟﺗﺟزﺋﺔ‬ ‫‪9.3.1‬‬ ‫إذا ﻛﺎﻧت اﻹﺟﺎﺑﺔ ﺑﻼ‪ ,‬ھل ﺗﺧطط ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﻟﺑدء إرﺳﺎل اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 9.4‬إذا ﻛﺎﻧت ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺗﺗوﻟﻰ أﻧﺷطﺔ ﺗﺟزﺋﺔ اﻟﺑﻼزﻣﺎ‪ ،‬ھل ﺗﻘدم ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﻣﺷورة‬ ‫ﻟﻠﻣﺗﺑرﻋﯾن ﻋﻧدﻣﺎ ﯾﺗم اﻟﺗﺧﻠص ﻣن اﻟﺑﻼزﻣﺎ؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪ 9.5‬إذا ﻛﺎﻧت ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺗﺗوﻟﻰ أﻧﺷطﺔ ﺗﺟزﺋﺔ اﻟﺑﻼزﻣﺎ‪ ،‬ھل ھﻲ ﺷﻔﺎﻓﺔ وﺧﺎﺿﻌﺔ ﻟﻠﻣﺳﺎءﻟﺔ‬ ‫ﻟﻠﻣﺗﺑرﻋﯾن؟‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫‪9.5.1‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم أو ﺟزﺋﯾﺎ‪ ,‬ﻣﺎ اﻟذي ﺗﻘوم ﺑﮫ ﺧدﻣﺔ ﻧﻘل اﻟدم ﻟﺿﻣﺎن اﻟﺷﻔﺎﻓﯾﺔ واﻟﻣﺳﺎءﻟﺔ؟‬ ‫‪9.6‬‬ ‫إذا ﻛﺎﻧت ﺧدﻣﺔ ﻧﻘل اﻟدم‪ /‬اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ ﺗﺗوﻟﻰ أﻧﺷطﺔ ﺗﺟزﺋﺔ اﻟﺑﻼزﻣﺎ أو ﺗرﺳل اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ إﻟﻰ ﻣﺻﻧﻊ‬ ‫ﺗﺟزﺋﺔ ﺧﺎرﺟﻲ‪ ،‬ھل ھﻧﺎك ﻣواﻓﻘﺔ رﺳﻣﯾﺔ ﻣن اﻟﺣﻛوﻣﺔ ﻋﻠﻰ ﻋﻣﻠﯾﺔ اﻟﺗﺻﻧﯾﻊ و‪ /‬أو اﻟﺗﺳوﯾﻖ؟‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻧﻌم‬ ‫ﺟزﺋﯾﺎ‬ ‫)ﯾرﺟﻰ‬ ‫إﻋطﺎء‬ ‫ﺗﻔﺎﺻﯾل(‬ ‫ﯾرﺟﻰ إﻋطﺎء اﻟﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻻ ﺗﺗردد ﻓﻲ ﺗﻘدﯾم ﺗﻌﻠﯾﻘﺎت أﺧرى أو ﻣزﯾد ﻣن اﻟﻣﻌﻠوﻣﺎت ﻟﺗوﺿﯾﺢ ردودﻛم ﻋﻠﻰ ھذا اﻟﻘﺳم‪:‬‬ ‫ﻻ‬ ‫ﻏﯾر ﻣﻌروﻓﺔ‬ ‫اﻟﻘﺳم ب ‪ -‬ﻧظرة ﻋﺎﻣﺔ ﻋﻠﻰ أﻧﺷطﺔ ﺧدﻣﺎت ﻧﻘل اﻟدم‬ ‫ﯾرﺟﻰ ﺗﻘدﯾم ﻟﻣﺣﺔ ﻣوﺟزة ﻋن ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك‪ ،‬ﻣﻊ أﺣدث اﻟﺑﯾﺎﻧﺎت اﻟﻣﺗﺎﺣﺔ ﻟك‪.‬‬ ‫ﺳوف ﯾﺳﺎﻋد ھذا اﻟﻘﺳم ﻓﻲ ﺗﺣدﯾد ﺻورة ﺷﺎﻣﻠﺔ ﻷﻧﺷطﺔ اﻟدم ﻓﻲ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺧﺎﺻﺔ ﺑك‪،‬‬ ‫واﻟﻣﺳﺎﻋدة ﻓﻲ ﺗﻘﯾﯾم اﻟﺗﻘدم اﻟﻣﺣرز ﺑﻣرور اﻟوﻗت‪.‬‬ ‫‪0‬‬ ‫‪0‬‬ ‫اﻟدوﻟﺔ‬ ‫اﺳم اﻟﻣﻧظﻣﺔ‬ ‫ﻋﺎم ﺑدء ﺧدﻣﺔ ﻧﻘل اﻟدم‬ ‫ﻋدد ﻣوظﻔﻲ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫اﻟﻣﺷﺎرﻛﯾن ﻓﻲ ﺧدﻣﺔ ﻧﻘل اﻟدم )وﻟﯾس ﻣوظﻔﻲ‬ ‫اﻟﻣﺳﺗﺷﻔﻰ(‬ ‫اﻟﻣﯾزاﻧﯾﺔ اﻟﺳﻧوﯾﺔ اﻟﺣﺎﻟﯾﺔ‬ ‫ﺗﺣدﯾد اﻟﻌﺎم اﻟذي ﺗﺷﯾر إﻟﯾﮫ ھذه اﻟﻣﯾزاﻧﯾﺔ )ﺗﺣدﯾد ﻣن ﺷﮭر‪ /‬ﺳﻧﺔ إﻟﻰ ﺷﮭر‪ /‬ﻣن‬ ‫ﺳﻧﺔ(‬ ‫]ﺗﺣدﯾد اﻟﻌﻣﻠﺔ[‬ ‫إﻟﻰ‬ ‫إذا ﻛﺎن ھﻧﺎك ﻣﻘدﻣﯾن آﺧرﯾن ﻟﺧدﻣﺎت ﻧﻘل اﻟدم ﻓﻲ ﺑﻠدك‪ ،‬رﺟﺎء ﺗﻘدﯾم ﻗﺎﺋﻣﺔ ﺑﮭم )ﻣﺛل أﻓﺿل ﺧﻣس ﻣﻘدﻣﯾن(‬ ‫‪      ‬ﻣﻊ ﺣﺻﺗﮭم اﻟﺗﻘرﯾﺑﯾﺔ ‪ ٪‬ﻟﺗﻐطﯾﺔ اﻟﺧدﻣﺎت اﻟﻌﺎﻣﺔ‪:‬‬ ‫ﺣﺻﺔ ‪%‬‬ ‫اﻻﺳم‬ ‫‪.1‬‬ ‫‪.2‬‬ ‫‪.3‬‬ ‫‪.4‬‬ ‫‪.5‬‬ ‫ﯾرﺟﻰ إرﻓﺎق‪:‬‬ ‫اﻟﮭﯾﻛل اﻹداري‬ ‫اﻟﮭﯾﻛل اﻟﺗﻧظﯾﻣﻲ‬ ‫ﺷرﻛﺎء اﻟدﻋم اﻟﺗﻘﻧﻲ )ﯾرﺟﻰ ذﻛرھم(‬ ‫ﻋدد ﻣن اﻟﻣواﻗﻊ اﻟﺛﺎﺑﺗﺔ‬ ‫ﻋدد ﻣن اﻟﻣواﻗﻊ اﻟﻣﺗﻧﻘﻠﺔ‬ ‫ﻋدد إﺟﻣﺎﻟﻲ اﻟﻣﺟﻣوﻋﺎت ﺳﻧوﯾﺎ*‬ ‫ﻋدد ﻣﺟﻣوﻋﺎت اﻟدم اﻟﻛﺎﻣﻠﺔ ﺳﻧوﯾﺎ*‬ ‫إذا ﻛﺎن ذﻟك ﻣﻣﻛﻧﺎ‪ ،‬ﻋدد ﻣﺟﻣوﻋﺎت ﻓﺻﺎدة‪:‬‬ ‫< اﻟﺑﻼزﻣﺎ )وﺣدات ﺑﻼزﻣﺎ اﻟﻔﺻﺎدة‪ /‬اﻟﺳﻧﺔ(‬‫‪ <-‬اﻟﺻﻔﺎﺋﺢ اﻟدﻣوﯾﺔ‬ ‫ﻣﻠل ﻟﻛل وﺣدة‬ ‫اﻟوﺣدات‬ ‫< ﺧﻼﯾﺎ اﻟدم اﻟﺣﻣراء )وﺣدات ﻣن اﻟﺻﻔﺎﺋﺢ اﻟدﻣوﯾﺔ ﻟﻠﻔﺻﺎدة‪ /‬اﻟﺳﻧﺔ(‬‫إذا ﻛﺎن ذﻟك ﻣﻣﻛﻧﺎ‪ ،‬ﻛﻣﯾﺔ اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ ﺳﻧوﯾﺎ* )طن(‪:‬‬ ‫* إذا ﻛﺎﻧت ﺳﻧﺔ اﻟﻣﺟﻣوﻋﺎت ﻣﺧﺗﻠﻔﺔ ﻋن ﺳﻧﺔ اﻟﻣﯾزاﻧﯾﺔ‪ ،‬ﯾرﺟﻰ ﺗﺣدﯾد اﻟﺳﻧﺔ اﻟﺗﻲ ﺗﺷﯾر إﻟﯾﮭﺎ اﻟﻣﺟﻣوﻋﺎت‬ ‫]إدراج ﺷﮭر‪ /‬ﺳﻧﺔ[‬ ‫]إدراج ﺷﮭر‪ /‬ﺳﻧﺔ[‬ ‫إﻟﻰ‬ ‫إﻟﻰ‪:‬‬ ‫اﻻﻛﺗﻔﺎء اﻟذاﺗﻲ ﻣن اﻟﺑﻼزﻣﺎ‬ ‫ھل ﻛﻣﯾﺔ اﻟﺑﻼزﻣﺎ ﻟﻠﺗﺟزﺋﺔ ﻛﺎﻓﯾﺔ ﻟﺗﻠﺑﯾﺔ ﻣﺗطﻠﺑﺎت ﺑﻠدك؟‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫إذا ﻛﺎن اﻟﺟواب ﻻ‪ ,‬ﯾرﺟﻰ ذﻛر أﻋﻠﻰ ‪ 5‬ﻣﻧﺗﺟﺎت ﻟﻠﺗﺟزﺋﺔ ﺣﺳب اﻟﻣﺻدر‪:‬‬ ‫اﻟﻣﻧﺗﺞ‬ ‫‪.1‬‬ ‫‪.2‬‬ ‫‪.3‬‬ ‫‪.4‬‬ ‫‪.5‬‬ ‫ﻣﺳﺗورد ﻣن‬ ‫اﻟدوﻟﺔ‬ ‫اﻟﺷرﻛﺔ‬ ‫اﻟﻘﺳم ب ‪ -‬ﻧظرة ﻋﺎﻣﺔ ﻋﻠﻰ أﻧﺷطﺔ ﺧدﻣﺎت ﻧﻘل اﻟدم )ﻣﺗﺎﺑﻌﺔ(‬ ‫ھل ﻟدﯾك ﻓﺎﺋض ﻣن اﻟﺑﻼزﻣﺎ أو ﻣﻧﺗﺟﺎت اﻟﺑﻼزﻣﺎ؟‬ ‫ﻧﻌم‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم ﻣﺎذا ﯾﺣدث ﻟﻠﻔﺎﺋض ﻣن اﻟﻣﻧﺗﺟﺎت؟‬ ‫اﻟﺗﺧﻠص ﻣﻧﮭﺎ‬ ‫ﺑﯾﻌﮭﺎ إﻟﻰ‬ ‫]ﺗﺣدﯾد اﻟﺑﻠد[‬ ‫]ﺗﺣدﯾد اﻟﺑﻠد[‬ ‫ﺑﯾﻌﮭﺎ إﻟﻰ‬ ‫ﻏﯾر ذﻟك ﯾرﺟﻰ ﺗﺣدﯾد ذﻟك‪:‬‬ ‫ﻻ‬ ‫ﻋﻠﻰ اﺳﺗرداد اﻟﺗﻛﺎﻟﯾف‬ ‫ﺑرﺑﺢ‬ ‫إذا ﺗم ﺑﯾﻊ ﻣﻧﺗﺟﺎت ﻣﺧﺗﻠﻔﺔ ﻟدول ﻣﺧﺗﻠﻔﺔ‪ ،‬ﯾرﺟﻰ اﻟﺗوﺿﯾﺢ أدﻧﺎه‪:‬‬ ‫ھل ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك ﺣﺎﻟﯾﺎ ﺗﺷﺎرك ﻓﻲ أي ﻣن ﻋﻼﺟﺎت اﻟﺧﻼﯾﺎ أو اﻷﻧﺳﺟﺔ اﻟﺗﺎﻟﯾﺔ?‬ ‫ﻧﻌم‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ ﻟﻠﺣﺑل اﻟﺳري‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ اﻟدﻣوﯾﺔ اﻟﻣﺣﯾطﯾﺔ‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ ﻟﻧﺧﺎع اﻟﻌظﺎم‬ ‫زرع اﻷﻋﺿﺎء اﻟﺻﻠﺑﺔ‬ ‫اﻟﻌظﺎم‬ ‫اﻟﻘرﻧﯾﺔ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ اﻟﺗﺣدﯾد‬ ‫ﻻ‬ ‫(‪:‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﯾرﺟﻰ ﺗﻘدﯾم ﺗﻔﺎﺻﯾل ﻋن ﻣﺳﺗوى وﻧوع اﻟﻧﺷﺎط وﻧطﺎق اﻟﻣﺷﺎرﻛﺔ )ﻣﺛل ﺟﻣﻊ‪ /‬ﺣﺻﺎد اﻟﺗﺳﺟﯾل واﻟﻣﻌﺎﻟﺟﺔ واﻟﺗﺧزﯾن واﻻﺧﺗﺑﺎر(‬ ‫ھل ﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك ُﺗﺧطط ﻟﻠﻣﺷﺎرﻛﺔ ﻓﻲ أي ﻣن ﻋﻼﺟﺎت اﻟﺧﻼﯾﺎ أو اﻷﻧﺳﺟﺔ اﻟﺗﺎﻟﯾﺔ ﻓﻲ اﻟﺳﻧوات ‪ 2-1‬اﻟﻘﺎدﻣﺔ?‬ ‫ﻧﻌم‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ ﻟﻠﺣﺑل اﻟﺳري‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ اﻟدﻣوﯾﺔ اﻟﻣﺣﯾطﯾﺔ‬ ‫اﻟﺧﻼﯾﺎ اﻟﺟذﻋﯾﺔ ﻟﻧﺧﺎع اﻟﻌظﺎم‬ ‫زرع اﻷﻋﺿﺎء اﻟﺻﻠﺑﺔ‬ ‫اﻟﻌظﺎم‬ ‫اﻟﻘرﻧﯾﺔ‬ ‫ﻏﯾر ذﻟك )ﯾرﺟﻰ اﻟﺗﺣدﯾد‬ ‫ﻻ‬ ‫(‪:‬‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﯾرﺟﻰ ﺗﻘدﯾم ﺗﻔﺎﺻﯾل ﻋن اﻟﻧﺷﺎط اﻟﻣﺧطط وﻧطﺎق اﻟﻣﺷﺎرﻛﺔ )ﻣﺛل ﺟﻣﻊ‪ /‬ﺣﺻﺎد اﻟﺗﺳﺟﯾل واﻟﻣﻌﺎﻟﺟﺔ واﻟﺗﺧزﯾن واﻻﺧﺗﺑﺎر(‬ ‫اﻟﻘﺳم ب ‪ -‬ﻧظرة ﻋﺎﻣﺔ ﻋﻠﻰ أﻧﺷطﺔ ﺧدﻣﺎت ﻧﻘل اﻟدم )ﻣﺗﺎﺑﻌﺔ(‬ ‫اﻻﺗﻔﺎﻗﯾﺎت اﻟﺛﻧﺎﺋﯾﺔ‬ ‫ھل ﺗﺷﺎرك ﻓﻲ أي ﺑراﻣﺞ دﻋم ﺛﻧﺎﺋﯾﺔ ﻟﺧدﻣﺔ ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑك؟‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﯾرﺟﻰ إﻋطﺎء ﺗﻔﺎﺻﯾل‪:‬‬ ‫ھل ﺗﺗﻠﻘﻲ أﻣوال ﻣن ﻣﺻﺎدر أﺧرى ﻟدﻋم اﻟﺗرﺗﯾﺑﺎت اﻟﺛﻧﺎﺋﯾﺔ؟‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫إذا ﻛﺎن اﻟﺟواب ﺑﻧﻌم‪ ,‬ﯾرﺟﻰ إﻋطﺎء ﺗﻔﺎﺻﯾل‪:‬‬ ‫ﻗﺻص اﻟﻧﺟﺎح‬ ‫ھل ﺳﺗﻛون ﻋﻠﻰ اﺳﺗﻌداد ﻟﻣﺷﺎرﻛﺔ ﺑﻌض اﻟﻧﺟﺎﺣﺎت اﻟﻣﺣﻠﯾﺔ اﻟﺧﺎﺻﺔ ﺑك ﻣﻊ اﻵﺧرﯾن ﺑﺧدﻣﺔ ﻧﻘل اﻟدم ﺑﺎﻟﺻﻠﯾب اﻷﺣﻣر‪ /‬اﻟﮭﻼل اﻷﺣﻣر‬ ‫؟‬ ‫ﻧﻌم‬ ‫ﻻ‬ ‫اﻟﺧطوات اﻟﻣﻘﺑﻠﺔ‬ ‫اﻟﺧطوات اﻟﻣﻘﺑﻠﺔ اﻟﻣوﺻﻰ ﺑﮭﺎ‬ ‫ﯾﮭدف اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ إﻟﻰ ﺗﻣﻛﯾن اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ وﺧدﻣﺎت ﻧﻘل اﻟدم اﻟﺧﺎﺻﺔ ﺑﮭﺎ ﻟﺗﺣدﯾد اﻟﻣﺳﺎﺋل اﻟﺗﻲ ﺗﺗطﻠب ﻣزﯾدا ﻣن اﻻھﺗﻣﺎم‪ .‬ﻛل ﺳؤال ﻓﻲ‬ ‫اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ‪ SA‬ﯾﺻف ﺷرط واﻟذي‪ ،‬إذا ﻟم ﯾﺗم اﺳﺗﯾﻔﺎؤه‪ ،‬ﯾﻣﻛن أن ﯾﻣﺛل ﺧطرا ﻋﻠﻰ ﺧدﻣﺔ ﻧﻘل اﻟدم وﻋﻠﻰ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺧﺎﺻﺔ ﺑﮭﺎ‪.‬‬ ‫اﻟﺧطﺔ ﻟﻣواﺟﮭﺔ ﻛل اﻟﺷروط اﻟﺗﻲ ﻟم ﯾﺗم اﺳﺗﯾﻔﺎؤھﺎ ‪ -‬ﺑدءا ﻣن اﻟﺗﻲ ﺗﺣت اﻟﻘﺿﯾﺔ اﻟرﺋﯾﺳﯾﺔ ‪ - 1‬ﯾﺟب أن ﺗﻘﻠل إﻟﻰ ﺣد ﻛﺑﯾر ﻣن ﻣﺳﺗوى اﻟﻣﺧﺎطر‬ ‫ﻟﺧدﻣﺔ ﻧﻘل اﻟدم واﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ اﻟﺧﺎﺻﺔ ﺑﮭﺎ‪.‬‬ ‫ﻟﻠﻣﺳﺎﻋدة ﻓﻲ ﺧدﻣﺔ ﻧﻘل اﻟدم ﻓﻲ ﻣﻌﺎﻟﺟﺔ ﻣﺧﺎطرھﺎ اﻟﻣﺣددة‪ ،‬ﺳوف ‪ GAP‬ﺗزوﯾدھﺎ ﺗﻘﯾﯾم اﻟذاﺗﻲ ﺗﻘرﯾر ردود اﻟﻔﻌل اﻟﻔردي ﻣﻊ ﺗوﺻﯾﺎت إدارة‬ ‫اﻟﻣﺧﺎطر‪.‬‬ ‫ﻓﻲ ﻏﺿون ذﻟك‪ ،‬ﻗد اﻗﺗرح اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ ‪" GAP‬اﻟﺧطوات اﻟﺗﺎﻟﯾﺔ" اﻟﻣﺧﺗﻠﻔﺔ اﻟﻣﻣﻛﻧﺔ ﻟﻣراﻋﺎة ﺧدﻣﺔ ﻧﻘل اﻟدم أدﻧﺎه‪:‬‬ ‫اﻟﺣﻛم واﻹدارة‬ ‫‪ ‬إﻧﺷﺎء ﻓرﯾﻖ ﻋﻣل ﺑداﺧل اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ و‪ /‬أو ﺧدﻣﺔ ﻧﻘل اﻟدم ﻟﻣراﺟﻌﺔ‬ ‫اﻟﮭﯾﻛل اﻟﺣﺎﻟﻲ ﻟﻠﺣﻛم واﻹدارة اﻟﺗﺎﺑﻊ ﻟﻠﺧدﻣﺔ‪ ،‬وإﻋداد اﻟﺧطﺔ اﻻﺳﺗراﺗﯾﺟﯾﺔ‪.‬‬ ‫‪ ‬اﻟﻧظر ﻓﻲ اﻟﺣﺻول ﻋﻠﻰ اﻟﻣﺳﺎﻋدة اﻟﻣﺗﺧﺻﺻﺔ أو اﻟﻣﺷورة ﺑﺷﺄن ﻗﺿﺎﯾﺎ اﻟﺣﻛم واﻹدارة ﻣن‬ ‫اﻟﺟﻣﻌﯾﺎت اﻟوطﻧﯾﺔ اﻷﺧرى‪ /‬ﺧدﻣﺎت ﻧﻘل اﻟدم‪ ،‬أو ﻣن ﺧﻼل إﺷراك ﻣﺳﺗﺷﺎر ﺧﺎرﺟﻲ ﻣﺗﺧﺻص‪.‬‬ ‫‪ ‬ﯾﻣﻛن ﻟﻔرﯾﻖ اﻟﻌﻣل أو اﻟﻣﺳﺗﺷﺎر اﻟﻧظر ﻓﻲ ﻣﺎ ﯾﻠﻲ‪:‬‬ ‫○ ﯾوﻓر اﻟﮭﯾﻛل اﻟﺣﺎﻟﻲ اﻟرﻗﺎﺑﺔ اﻟﻛﺎﻓﯾﺔ‪ ،‬ووﺿوح اﻟﻣﺳؤوﻟﯾﺔ‬ ‫○ ﯾﺟب ﻓﺻل إدارة ﺧدﻣﺎت ﻧﻘل اﻟدم وإدارة اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ‬ ‫○ ﯾﻧﺑﻐﻲ إﻧﺷﺎء ﺧدﻣﺔ ﻧﻘل اﻟدم ﻛﻛﯾﺎن ﻗﺎﻧوﻧﻲ ﻣﺳﺗﻘل ﻋن اﻟﺟﻣﻌﯾﺔ‬ ‫○اﻟوطﻧﯾﺔ‬ ‫○ اﻟﺑﻧﯾﺔ اﻟﺗﻲ ﺗﻧطوي ﻋﻠﻰ ﻣﺟﻠس اﻹدارة اﻹﺷراﻓﻲ )ﻣﻊ ﻣﮭﺎم اﻟرﻗﺎﺑﺔ اﻻﺳﺗراﺗﯾﺟﯾﺔ(‬ ‫○واﻟرﺋﯾس اﻟﺗﻧﻔﯾذي‬ ‫○) اﻟﻣﺳؤول ﻋن اﻹدارة اﻟﯾوﻣﯾﺔ‪ ،‬وﺗﻘدﯾم اﻟﺗﻘﺎرﯾر إﻟﻰ ﻣﺟﻠس اﻹدارة(‬ ‫○ﻓرﯾﻖ اﻹدارة اﻟﻌﻠﯾﺎ‬ ‫○)ﺗﻘدﯾم اﻟﺗﻘﺎرﯾر إﻟﻰ اﻟرﺋﯾس اﻟﺗﻧﻔﯾذي( ﺳوف ﺗﻛون ﻗﺎﺑﻠﺔ ﻟﻠﺗطﺑﯾﻖ‬ ‫اﻟﻘﺿﺎﯾﺎ اﻟﻘﺎﻧوﻧﯾﺔ وإدارة اﻟﻣﺧﺎطر‬ ‫‪ ‬ﺗﺣدﯾد اﻷﺳﺎس اﻟﺗﺷرﯾﻌﻲ واﻟﺗﻧظﯾﻣﻲ ﻟﻌﻣﻠﯾﺎت ﺧدﻣﺔ ﻧﻘل اﻟدم‪ .‬ﺗﻘﯾﯾم ﻣﺎ إذا اﻟﻘواﻧﯾن واﻟﻠواﺋﺢ اﻟﺣﻛوﻣﯾﺔ اﻟﺣﺎﻟﯾﺔ‪:‬‬ ‫○ ﺗﻧص ﺑدﻗﺔ ﻋﻠﻰ اﻟﻌﻼﻗﺔ ﺑﯾن ﺧدﻣﺔ ﻧﻘل اﻟدم واﻟﺳﻠطﺎت اﻟﺣﻛوﻣﯾﺔ‬ ‫○اﻟﺗﻧظﯾم اﻟﻛﺎف ﻷﻧﺷطﺔ اﻟﺧدﻣﺔ‬ ‫○ ﺗﻘدﯾم ﺧدﻣﺔ ﻧﻘل اﻟدم ﻣﻊ أي ﺣﻣﺎﯾﺔ أو ﺗﻌوﯾض ﻋن اﻟﻣطﺎﻟﺑﺎت اﻟﻘﺎﻧوﻧﯾﺔ‬ ‫‪ ‬اﻟﻧظر ﻓﻲ ﻣﺎ إذا ﻛﺎﻧت اﻟﺗﻐﯾﯾرات اﻟﺗﺷرﯾﻌﯾﺔ ﻻزﻣﺔ‪ ،‬وأﻓﺿل اﻟﺳﺑل ﻟﺗﺣﻘﯾﻖ ﻣﺛل ھذه اﻟﺗﻐﯾﯾرات‪.‬‬ ‫‪ ‬اﻟﻧظر ﻓﻲ اﻟدﻋوة ﻣﻊ اﻟﺣﻛوﻣﺔ‪ ،‬واﻟﺳﻠطﺎت اﻟﺻﺣﯾﺔ اﻟﻌﺎﻣﺔ اﻟﻣﻧﺎﺳﺑﺔ‪ ،‬ﻟﻠﺣﺻول ﻋﻠﻰ اﻟدﻋم ﻟﮭذه اﻟﻣﻘﺗرﺣﺎت‪.‬‬ ‫‪ ‬إﻧﺷﺎء ﻓرﯾﻖ ﻹدارة اﻟﻣﺧﺎطر ﺑداﺧل ﺧدﻣﺔ ﻧﻘل اﻟدم‪ ،‬ﻹﺟراء ﺗﻘﯾﯾم ﻷﻧﺷطﺔ اﻟﺧدﻣﺔ وإﻋداد ﺳﯾﺎﺳﺎت ﻟﺗﺣدﯾد وﺗﻘﻠﯾل واﻟﻘﺿﺎء ﻋﻠﻰ اﻟﻣﺧﺎطر‪.‬‬ ‫اﻟﺗﻣوﯾل واﻟﺗﺄﻣﯾن‬ ‫‪ ‬ﻣراﺟﻌﺔ ﻣﺻﺎدر اﻟﺗﻣوﯾل وﻣﺻﺎدر اﻟدﺧل اﻟﻣﺣﺗﻣﻠﺔ‪ .‬ﺗﻘﯾﯾم ﻣﺎ إذا ﻛﺎﻧت اﺗﻔﺎﻗﯾﺎت اﻟﺧدﻣﺔ اﻟﺣﺎﻟﯾﺔ )إن وﺟدت( ﻣﻊ اﻟﺟﻣﻌﯾﺔ اﻟوطﻧﯾﺔ واﻟﮭﯾﺋﺎت‬ ‫اﻟﻌﺎﻣﺔ ﻛﺎﻓﯾﺔ‪ ،‬أو ﺗﺗطﻠب ﺗﻐﯾﯾرات‪.‬‬ ‫‪ ‬طﻠب اﻟﻣﺷورة ﺣول ﺗواﻓر وﺗﻛﻠﻔﺔ اﻟﺗﺄﻣﯾن اﻟﺷﺎﻣل ﻟﻠﺧدﻣﺔ وﻣوظﻔﯾﮭﺎ‪.‬‬ ‫اﻟﺳﯾﺎﺳﺎت واﻟﻣﻌﺎﯾﯾر‬ ‫‪ ‬إﺟراء ﻣراﺟﻌﺔ ﺗﺷﻐﯾﻠﯾﺔ ﻟﺗﻘﯾﯾم ﻣدى اﻻﻣﺗﺛﺎل ﻟﻣﻌﺎﯾﯾر ﺗﻘدﯾم ﺑرﻧﺎﻣﺞ ﻧﻘل اﻟدم اﻟدوﻟﻲ‪ .‬ﺗﺣدﯾد اﻟﺧطوات ﻟﺗﺣﺳﯾن اﻻﻣﺗﺛﺎل‪.‬‬ ‫‪‬ﻣراﺟﻌﺔ اﻟﺳﯾﺎﺳﺎت اﻟﺗﺷﻐﯾﻠﯾﺔ ) ﻋﻠﻰ ﺳﺑﯾل اﻟﻣﺛﺎل‪ ،‬اﻟﺳﯾﺎﺳﺎت ﻟﺗوظﯾف وﺗدرﯾب اﻟﻣوظﻔﯾن‪ ،‬ﺣﻔظ اﻟوﺛﺎﺋﻖ وﻣواﻓﻘﺔ اﻟﻣرﯾض اﻟﻣﺳﺗﻧﯾرة‪ ،‬واﻟﺗﺛﻘﯾف‬ ‫اﻟﻌﺎم‪ ،‬واﻟﻌﻼﻗﺎت اﻹﻋﻼﻣﯾﺔ‪ ،‬وھﻠم ﺟرا(‪.‬‬ ‫‪ ‬اﻟﻣراﺟﻌﺔ ﺑﻣﻧﮭﺟﯾﺔ وﺗﺣدﯾد أوﻟوﯾﺎت اﻟﻘﺿﺎﯾﺎ اﻟرﺋﯾﺳﯾﺔ واﻟﻧﻘﺎط اﻟرﺋﯾﺳﯾﺔ ﻣن اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ‪ ،‬ودﻣﺟﮭﺎ ﻓﻲ ﻣواد اﻟﺳﯾﺎﺳﺎت واﻟﺗﺧطﯾط‪.‬‬ ‫‪ ‬ﺗﻛرار اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ ﺑﺷﻛل دوري ﻣن أﺟل اﺳﺗﻌراض اﻟﺗﻘدم اﻟﻣﺣرز‪.‬‬ ‫اﻟﺗﻌﻠﯾﻘﺎت اﻟﻧﮭﺎﺋﯾﺔ‬ ‫اﻟﺗﻌﻠﯾﻘﺎت اﻟﻧﮭﺎﺋﯾﺔ‪:‬‬ ‫ﯾرﺣب اﻟﻔرﯾﻖ اﻻﺳﺗﺷﺎري اﻟﻌﺎﻟﻣﻲ ﺑﺎﻟﺗﻌﻠﯾﻘﺎت واﻟﻣﻼﺣظﺎت ﺧﻼل ﻋﻣﻠﯾﺔ اﻻﻧﺗﮭﺎء ﻣن ھذا‬ ‫اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ‪ .‬ﻧﺣن ﻣﮭﺗﻣون ﺑﻣن ﺷﺎرك واﻻﻗﺗراﺣﺎت ﻹﺟراء اﻟﺗﻐﯾﯾرات‪ ،‬أو ﻏﯾرھﺎ ﻣن‬ ‫اﻟﺗﻌﻠﯾﻘﺎت اﻷﺧرى‪.‬‬ ‫ﺷﻛرا ﻟﻛم‬ ‫ﺷﻛرا ﺟزﯾﻼ ﻋﻠﻰ ﻣﺷﺎرﻛﺗﻛم ﻓﻲ اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ‪ .‬إذا ﻛﺎن ﻟدﯾك أي ﻣﻌﻠوﻣﺎت أو ﻣﻼﺣظﺎت أﺧرى ﺗرﻏب ﻓﻲ ﺗﻘدﯾﻣﮭﺎ‪ ،‬ﯾرﺟﻰ إرﺳﺎﻟﮭﺎ ﻋن طرﯾﻖ اﻟﺑرﯾد‬ ‫اﻹﻟﻛﺗروﻧﻲ إﻟﻰ‪:‬‬ ‫‪GAPSelfAssessment@redcrossblood.org.au‬‬ ‫ﯾرﺟﻰ ﺗوﻗﻊ اﻟﺣﺻول ﻋﻠﻰ ﺗﻘرﯾر اﻟﺗﻌﻠﯾﻘﺎت اﻟﻔردﯾﺔ اﻟﺧﺎﺻﺔ ﺑك ﻋﻧد اﻻﻧﺗﮭﺎء ﻣن ﻋﻣﻠﯾﺔ اﻟﺗﻘﯾﯾم اﻟذاﺗﻲ داﺧل ﻣﻧطﻘﺗك‪.‬‬
Introduction to the Global Advisory Panel (Presentation)
Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Introduction to the Global Advisory Panel 20th September 2014 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Presentation Overview  Background to GAP • Establishment • Vision/mission • Structure/Membership  Global Mapping  Core Activities  GAP Tools & Resources • GAP Manual • Self-Assessment • Knowledge sharing • Priority country Assistance  Contacts Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Who is GAP GAP is an association which provides advice to National Red Cross and Red Crescent Societies, and their affiliated blood services, in matters concerning corporate governance and risk management in the field of national society blood programmes, as well as the IFRC Secretariat and other relevant IFRC bodies. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Establishment Nov 2000 - International Federation of Red Cross/Red Crescent (IFRC) ceased technical support to National Society Blood Services (NSBS) and focussed on promotion of VNRBD. May 2001 - GAP was formed from experts from national societies with strong blood programmes. 2011 - IFRC Blood Policy approved by General Assembly July 2012 - GAP established as separate legal entity to IFRC (Association under Swiss civil code) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies IFRC Blood Policy  November 2011 - IFRC blood policy “Promoting Safe and Sustainable Blood Systems” approved by the General Assembly.  The policy outlines the responsibilities of IFRC, GAP, national societies and blood services in managing the risks associated with operating a blood program  GAP’s primary purpose is to provide advice, tools resources and support to NSBS to assist in managing these risks. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Vision and Mission Vision: All Red Cross/Red Crescent blood programmes will be safe, well governed and self sustainable based on the principle of voluntary non remunerated blood donation for the benefit of patients and to safeguard blood donors. Mission: GAP will support Red Cross/Red Crescent blood services in risk management, corporate governance of blood programmes and promote good practices and knowledge exchange. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP mandate Consider and promote blood programme corporate governance and risk management issues Recommend and promote appropriate risk management structures and processes at a regional level Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Structure & Membership Formal structure - Election of President and Executive Board GAP Members - Experts drawn widely from the RC/RC global membership, with relevant expertise in blood Current membership – 12 NSBS IFRC permanent observer - links to the IFRC Secretary General and connected to the Federation’s Health and Social Care programs. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Member Zones      Asia & Pacific Africa Europe & Central Asia Middle East & Northern Africa Americas – Latin America & The Caribbean  Zone Coordinators provide regional coordination of activities Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP member blood services        America (US) Australia Austria Belgium (President) Finland Germany Honduras  Hong Kong (China)  Israel (MDA)  Japan  Switzerland  Thailand Observers: IFRC Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies National Society involvement in blood programmes LEVEL A. Full Blood Service Provision  Governance  Advocacy for appropriate use  Product distribution  Laboratory testing  Component preparation Donor recruitment  Collection services/donor care  Donor recruitment Promotional campaigns Education and awareness  Promotional campaigns Involvement in WBDD  Education and awareness  Involvement in WBDD LEVEL B. Systematic Blood Donor Recruitment C. Advocacy for VNRBD Promotional campaigns Education and awareness Involvement in WBDD Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Global mapping  New global mapping process conducted 2013/14  71 countries responded. 85% of these NS reported having some involvement in the blood program: 26 Level A - full blood service (37%) 19 level B - recruitment of donors(27%) 15 level C - donor motivation, advocacy (21%) 11 nil - no involvement (15%)  GAP Self Assessment distributed to all Level A NS Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Core GAP Activities  Provide technical advice on corporate governance and risk management  Promote knowledge sharing, networking and partnership among Red Cross and Red Crescent blood services  Develop Blood Service tools, resources and guidelines  Provide priority country support to NS most in need  Focus on level A blood programmes  Support IFRC VNRBD programme Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Tools & Resources GAP Manual Self-Assessment questionnaire Knowledge Sharing/Networking Priority Country Assistance Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Manual GAP manual: Development of Safe and Sustainable National Blood Programmes  Provides guidance for national societies (NS) on managing blood program related risks.  Available on IFRC website: https://fednet.ifrc.org/en/resources/heal th-and-care/blood/materials-and-tools Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire  Distributed to NSBS to enable them to identify their corporate governance and risk management issues  Focusses on the fundamental aspects NS should consider when undertaking blood programme activities  GAP collates results and prepares individual feedback reports which are provided to NSBS with advice and suggested strategies to improve risk management and corporate governance Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire Types of risks that may be identified in SA  Lack of government protection for blood borne disease transmission and/or appropriate insurance  Inability to meet regulatory or national standards  Lack of funding and resources – affecting BS ability to manage risks and implement donor and product safety systems/processes  Lack of systems to identify/analyse, evaluate, prioritise and manage risks Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire Types of risks that may be identified in SA  Ineffective government and lack of clear separation of blood service and national society regarding corporate management of blood service activities  Lack of systems to monitor emerging threats to blood supply  Lack of practical support to recipients of infected blood Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire Major Material Risk (MMR) Defined as: “A circumstance in which an individual NS or Blood Service knowingly endangers a high number of donors and/or recipients or acts in contravention to the principles of the Federation, thereby exposing the IFRC or sister NS to potential reputational damage” Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Self-Assessment Questionnaire Major Material Risk (MMR)  GAP has developed a process to identify, manage and monitor and if applicable report MMR in conjunction with the IFRC  GAP support is provided to NSBS most in need, to assist in risk monitoring and strategies for risk mitigation Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Knowledge sharing/networking Regional meetings  Results (de-identified) of the SA are discussed at GAP regional meetings. • Sharing of ideas and strategies to address regional issues • Opportunities for buddying/twinning  Where major material risks are identified, GAP liaises with IFRC  SA Results assist the identification of GAP priority countries requiring further specific support Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Priority Country Assistance  1-2 priority NS identified each year for specific technical assistance  Support provided by GAP in 2012/14 ranged from high level support through to dedicated technical assistance  Current GAP priority NS are: Nepal Haiti Vietnam Honduras Bangladesh Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Priority Country Assistance Examples of some types of support GAP may offer:  Advocacy with governments and Ministries of Health  Provision of best practice examples of key governance documentation – Memorandum of Understanding, Blood Policies, strategic plans  Assistance in the development of appropriate risk management systems and frameworks  Assistance in strategic planning  Provision of training and workshops  Advice on national coordination of the blood program  Coordination of partnering assistance with other NSBS Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Priority Country Assistance High level support - Example:  Assisted NSBS with Government and National Public Health Laboratory regarding appropriate funding for blood donation screening.  Government commitment achieved to fund ELISA testing equipment for screening blood donations for TTI.  Director confirmed all blood donations collected in region now screened for TTI on ELISA. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Priority Country Assistance Technical support – Example:  Dedicated technical support visit to assist NSBS to develop an operationalised strategic plan. • Key activities prioritised • Deliverables planned over 3 year period • Budgetary requirements for key strategic activities identified  The strategic plan is being used to assist and leverage NSBS applications for external funding to support its future program Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP support to NS blood programmes Video – IFRC Blood policy and GAP Describes the role of GAP in supporting NSBS and the tools and resources available for assistance. Refer: link on IFRC website https://fednet.ifrc.org/en/resources/health-and-care/blood/ Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Conclusion In coordination with partners, GAP will continue to provide support to national society blood services at a global, regional and country level. GAP will continue to : • Provide a networking forum for the sharing of risk management/corporate governance challenges and solutions with NSBS • Provide tools, resources and priority country assistance to those NSBS most in need • Provide advocacy and support to IFRC and NSBS on issues affecting blood programmes • Coordinate disaster response support for blood services • Influence global blood policy in conjunction with its partners Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies How to contact GAP Email gapsecretariat@redcrossblood.org.au Website  Currently in development and will be completed early 2015 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies GAP Providing advice and support to NSBS on governance and risk management of blood programmes at a global, regional and country level. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Any Questions
Blood Donor Counselling (Presentation)
Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Blood Donor Counselling A presentation for the Nepal Red Cross Society Blood Transfusion Service Dr Che Kit Lin On behalf of GAP and Hong Kong Red Cross 26th August 2014 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Purpose and Outcomes of Workshop 1. Clarify the importance of blood donor counselling 2. Discuss when and how to perform counselling 3. Identify opportunities for improvements in your own centres Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies What is blood donor counselling? Counselling is the confidential dialogue between a blood donor and counsellor about issues related to donor health and the donation process1 An important part of donor management and care 1. WHO – Blood Donor Counselling Implementation Guidelines, WHO/IFRC 2013 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Why counsel donors  Assists donors to give informed consent  Reduces donation by unsuitable donors (decrease wastage)  Promotes healthy lifestyles  May reduce adverse donor reactions  Can improve donor perception of blood service (encourage return) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Why counsel donors  The blood transfusion service has a responsibility to confirm positive or reactive test results and notify and counsel infected individuals  Counselling donors positive for transfusion transmissible infection (TTI) offers an early entry point to treatment and care  Health impacts extend beyond donors to their families and the general population Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Establishing a National system  Management and counselling of donors is an essential part of the donation process  National health authorities and BTS are responsible for ensuring that policies, guidelines and infrastructure are in place to ensure a reliable counselling system  There should be SOPs and documentation for all stages of donor counselling  Manual or electronic records should exist which ensure confidentiality and traceability (donor records, donor deferral registry)  Provide specific training on communication and counselling for all staff involved in counselling at any stage Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Where to perform counselling     Visual and audible privacy Maintain confidentiality Use room dividers/screens or utilise offices Ensure donor can feel welcome and comfortable answering questions honestly  Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Counselling Skills Counsellors should be trained professionals with an in-depth knowledge of: • • • • • • • Health requirements for safe blood donors Infections that are transfusion transmissible Lifestyle behaviours that increase the risk of TTI Donor selection/deferral Process of donation and potential reactions Blood components and testing performed Availability of donor care services including other health-care providers Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Counselling Skills Careful listening – enables the donor to share Attentive listening - Eye contact, tone of voice, using language “Yes”, “I see” Reflective listening – paraphrasing Using open ended questions Give helpful feedback Maintain focus on the topic of counselling (try to prevent distracted conversation) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies WHO Blood Donor Counselling – Implementation Guidelines Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies When to perform donor counselling Pre-donation information Pre-donation counselling (questionnaire, interview, health and risk assessment, informed consent) Counselling during blood donation Non-reactive Self-deferral Reactive/Indeterminate (confirmatory testing on same and/or new sample) Blood screening for TTI Post-donation self-deferral Negative Positive/Indeterminate Deferral or self-deferral Retain as regular donor and reinforce healthy lifestyle Post-donation counselling (notification, counselling and/or referral) Healthcare providers for continuing care and management Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation information  Information given to donors to allow them to make an informed decision before donation  Can be given by trained blood service staff or volunteers  May be given verbally or in written form using authorised blood service materials Wall posters Booklet Information sheet Verbal information Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation information To increase donor awareness of: • Blood Transfusion Service responsibility to maintain confidentiality and health of the donor • The steps in the donation process • Importance of the safety of donated blood • Importance of VNRBD • The purpose of screening for transfusion transmissible infections (TTI) To ensure donor’s trust in the blood service To encourage self-deferral (due to health, TTI, behaviour or travel) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation information should include: The importance of VNRBD Donor’s rights and responsibilities and options to withdraw at any time Blood donation process, availability of trained staff Potential complications (fainting, bruising) Tests performed on donated blood for TTI (limitations/window period) Procedure in the event of a positive test result Donor confidentiality Importance of regular donations Donation intervals High risk behaviour and how to avoid infection risk Importance of maintaining a healthy lifestyle How to self-defer Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre - donation counselling  A confidential discussion conducted by a trained medical doctor or a nurse/lab staff  Occurs before every donation as a routine step in the selection of the donor  Donor must answer questionnaire with accurate and consistent information AIMS: • Give information to the donor • Provide advice and answer any questions or concerns • Refer donor for further treatment if required Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation counselling DONOR DEFERRAL: When donors don’t meet the criteria for selection Temporary: Permanent: • Donor usually healthy but unsuitable on a particular occasion eg medication/travel/recovering from illness • Can donate once circumstances for deferral no longer exist • Important to provide information on further management if appropriate • Behaviour – high risk for TTI • Serious medical illness Can be self-deferral if donor has been exposed to a TTI Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Pre-donation counselling DONOR DEFERAL Donor may have negative feelings of rejection: • • • • Counsellor must be sensitive to these feeling Provide clear explanation Maintain confidentiality Refer for further treatment if required Important to counsel appropriately to encourage temporarily deferred donors to return • Give information on the reason for deferral and how to have a healthy lifestyle • Provide a date that they are eligible to return (if temporary) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Counselling during donation  Provide information on the venepuncture procedure  Show appreciation to donor for the valuable contribution; gain donor trust to encourage return  Makes donor feel comfortable; reduce worry  Minimise possibility of a reaction  Give advice regarding post-donation care • Ensure donor understands importance of informing blood service (post-donation) if blood may not be safe for transfusion • Donor to advise if they have an infection or reaction post donation Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Which donors need counselling  Donors who request self-exclusion post-donation due to possible risk of TTI  Donors who are found to have positive or reactive tests for TTI or who have unusual blood cell serology results  Donors who have experienced adverse reactions during or after blood donation Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling All donors who require post donation counselling require: Prompt counselling Assurance of CONFIDENTIALITY Face to face counselling is best, if not possible then phone counselling is the next best option A trained professional who can provide counselling with empathy Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling All donors who require post donation counselling require: Sufficient time to permit donor questions Accurate and consistent information Referral for appropriate clinical management Post-donation availability of results and the notification of abnormal results should be explained to the donor Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling The AIMS of post-donation counselling:  To obtain a fresh sample for additional confirmation if required  To explain: • test results • the need for confirmation of the results • the health implications for the donor • eligibility for blood donation in the future • The donor’s rights regarding disclosure  To encourage donors to disclose sensitive information, including the possible source of the infection Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling The AIMS of post-donation counselling:  To clarify doubts and concerns raised by donors  To alleviate donors’ worry and provide psychological support  To advise donors on precautions for preventing the transmission of TTIs to others (safe behaviour)  To refer donors for further investigations, management, treatment and care, if necessary Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Invite the donor to attend a counselling session by letter or phone Inform them that they are being contacted because one of the mandatory screening tests is abnormal and they need to return to discuss the result and implications with the doctor Verify the identify of the donor and inform that the counselling is confidential Inform the donor of the type of abnormal results they have simply and clearly (eg HCV, HBV, HIV, Syphilis) Give the donor time to consider the information and ensure they understand the result Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Discuss each test performed and the consequence of a positive result. Provide in a manner that is sensitive and appropriate to gender, culture, behaviour, language and geographical location of the donor Discuss the natural history of the disease if appropriate and health consequences, identify the possible source of infection and risk factors Check if the donor has any symptoms of the disease Encourage donor to ask further questions Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Provide donor details of: • Confirmatory testing available (other centres) • Options for further investigation, treatments and medical management Discuss precautions to prevent transmission: • Sharing implements, safe sex, hepatitis B vaccination Inform the donor that they can no longer donate blood Check if the donor’s partner is a blood donor or has donated in the past. • Advise donor to let their partner know so they can be tested and made aware of precautions Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Assess the donor’s reaction: • If negative – offer comfort and support until the donor is calm • Discuss how to manage or understand strong emotions and reactions including ways to deal with loss and grief, depression, anger and anxiety Assess all support available to the person, and ensure (where possible) referral to a support agency which can be accessed at the donor’s discretion. Recognise the impact that the test result may have on the donor Ensure the donor is provide with relevant information on the test result and future care/treatment Discuss possible disclosure of the result, including when and how this may happen and to whom Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling Identification of positive TTI in donor Give donor printed material to cover all aspects of the disease (precautions, treatment, referral and contact details of hospital health departments) Ensure the donor is aware they can come back at any time with queries or clarification Arrange a specific date and time for a follow-up visit or referral Add the donor to a permanent donor deferral registry which is kept confidential All notes are to be kept locked - Positive results should be coded to keep the result confidential Notify the Health department so burden of disease is known Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Donation Referral of donors with positive TTI Positive TTI identified (laboratory) How long for tests to be completed? Laboratory staff notify medical officers How long to notify medical officers/staff who will contact donor? Donor notified How long after donation is donor notified of positive TTI testing. Donor recalled Who recalls donor? Will donor come in to centre or counselling performed over the phone? Donor counselling Referral to specialist medical care (when required) Who performs the counselling? Who can provide specialist treatment? How is the donor referred? Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling BENEFITS      The abnormal results are provided to the donor in a safe and confidential environment. The donor is referred for management of TTI The donor understands the routes of transmission of TTI and can minimise further transmission Future donations from donors with confirmed TTI can be reduced with less risk to BTS staff and less wastage Can maintain donor/public confidence in blood centre, a deferred donor could still be an ambassador Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Post-donation counselling BENEFITS The BTS can collect demographic and risk exposure information about TTI positive donors as part of its haemovigilance program. This information can help in making future decisions about donor selection criteria and the usefulness of questions in the donor questionnaire. It can also help in informing marketing decisions about specific recruitment activities. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Challenges  Ensuring consistent messages to donors  Developing clear procedures to ensure consistency  Ensuring there are adequate physical facilities for confidential counselling  Ensuring there are specialist trained staff  Providing practical counselling training to staff  Difficulty contacting donors for counselling  Negotiating referral with healthcare providers Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Where to from here? SUGGESTIONS?  Develop a national policy on blood donor counselling  Develop national procedures for the management of donor counselling: • Testing procedures • Donor contact procedures • Timelines for contact • Staff training requirements • Referral practices Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Establishing a National system  Management and counselling of donors is an essential part of the     donation process National health authorities and BTS are responsible for ensuring that policies, guidelines and infrastructure are in place to ensure a reliable counselling system There should be SOPs and documentation for all stages of donor counselling Manual or electronic records should exist which ensure confidentiality and traceability (donor records, donor deferral registry) Provide specific training on communication and counselling for all staff involved in counselling at any stage Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Resources AABB - Blood Donor Health and Safety http://marketplace.aabb.org/EbusPPROD/Marketplace/AllProducts/ProductDetail.aspx?ProductId= 1330 WHO Blood Donor Counselling Implementation Guidelines www.who.int/bloodsafety/voluntary_donation/Blooddonorcounselling.pdf Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Group Activity - Handbook Blood donor counselling role play In small groups, act out the scenarios provided and then discuss together Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Questions Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Acknowledgements  Hong Kong Red Cross  Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies  AABB  WHO/IFRC – • Pre-donation Counselling and Donor Selection (Donor 5.2) • Post-donation Counselling (DP 5.6) • Post-donation Counselling (Donor 5.7) • Blood Donor Selection – Guidelines on Assessing Donor Suitability for Blood Donation • Blood Donor Counselling – Implementation Guidelines
Blood Donation Process (Presentation)
Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Blood Donation Process A presentation for the Nepal Red Cross Society National Blood Transfusion Service Ms Emily Tonks On behalf of GAP and Hong Kong Red Cross 26th August 2014 Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Purpose and Outcomes of Workshop  Clarify the steps in the blood donation process  Clarify the importance of standard operating procedures  Identify opportunities for improvements in your own centres Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Steps in donation process 1. 2. 3. 4. Reception/Registration (pre-donation information) Donor medical questionnaire completed Donor interview Health assessment (including Haemoglobin check and donor’s informed consent) 5. Donation 6. Post donation care and counselling (including treatment of adverse reactions) Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Donor Reception 1. Greet and welcome the donor 2. Check donor history Donor may have donated too recently or may have been told never to donate blood 3. Make sure that the donor has had food and fluids in the last 4 hours 4. Pre-donation information Explain the blood donation process 5. Give the donor a Blood Donor Form and Health Questionnaire to complete 6. Direct the donor to the waiting area to be seen by interviewing staff for the confidential interview. Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Donor questionnaire  Easy for donor to complete  No confusing questions  Gathers all relevant information on donor health and background  Relevant to the local population (local language)  Answers are discussed in donor interview Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Example of donor questionnaire (WHO) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Example of donor questionnaire (WHO) Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Donor Interview  Make sure donor is comfortable – privacy  Start by identifying the donor  Complete the Health Questionnaire with the donor if not already completed.  Check that the donor understands the question and explain they must answer honestly  Compare donor questionnaire/information with historical records Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Donor Interview  Donor to read the declaration statement (or staff read the declaration statement to donor) and sign and date  Fingerprint is acceptable if donor cannot sign If a donor cannot donate blood temporarily or permanently, explain the reason to the donor Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Donor Interview DONOR SELECTION GUIDELINES  National criteria for blood donor selection should be based on: • • • • • National/local epidemiological data on infectious diseases Nutritional and health status of the general population Local customs Health and safety outcomes – donors and recipients International best practice Should be reviewed regularly REF: WHO/IFRC Pre-donation counselling and donor selection Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Group Activity 1 - Handbook  Use of the Blood Donor Selection Guidelines Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Why do we have Donor Selection Guidelines  To make sure that it is safe for the donor to donate blood  To reduce the risk of transfusion-transmissible infection (TTI) or other adverse effects to blood recipients  To protect blood service staff  To build trust in the safety of the blood service Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Donor Health Screen Appearance • Donor must look well and not under the influence of drugs/alcohol Age • 18 – 60 years Weight • Min: 45kg (for 350ml collection) or >60kg (for 450ml collection) Blood Pressure (Nepal SOP) • Systolic: 110-160 mmHg • Diastolic: 70-96 mmHg Haemoglobin (Nepal SOP) • 12.0 g/dl (minimum) WHO Recommendations BP Systolic: 100-140 mmHg BP Diastolic: 60-90 mmHg Male Hb: 13.0 g/dl Female Hb: 12.0 g/dl Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Whole Blood Collection  Importance of PPE (personal protective equipment) and hygiene: • Always wear gloves • Iodine and alcohol swab to venepuncture site • Hand washing after procedure • Appropriate disposal of needles and equipment Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Whole Blood Collection Adverse reactions  Vasovagal episodes (fainting) and bruises/ haematomas at the venepuncture site are the most common  Staff should provide first aid and reassurance to donors  Serious reactions may require further medical treatment or referral Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation care Post donation donor care Donor to remain in chair for at least 5 minutes Donor to remain in refreshment area for at least 10 minutes • • Encourage donor to drink fluids Instruct donor to drink adequate fluid during the day following donation, and avoid strenuous exercise or lifting anything heavy for 4 hours. Instruct the donor to report any adverse reaction that may occur after leaving the centre • • • Provide the donor with a phone number for reporting adverse reactions Attend to donor adverse reactions if required Report all donor adverse events Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Reception/ Registration Donor questionnaire completed Donor interview Health assessment Donation Post donation donor care Post-donation information  Tell donor if they feel dizzy, lightheaded, sweating, nausea, yawning or feel hot, they should lie down with their feet elevated and drink plenty of water  Any bruising to the needle site will resolve  Ask donor to call if they become unwell in the 7 days following donation  Remind donor they will be contacted if their screening tests are abnormal  Give a leaflet of post donation instructions to the donor  Thank the donor – encourage them to come back in 12 weeks time to donate again. Post donation care Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Resources WHO Blood Donor Selection Guidelines on Assessing Donor Suitability for Blood Donation www.who.int/bloodsafety/publications/bts_guideline_donor_suitability/en/ Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Where to from here  Update Standard Operating Procedures  Staff training Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Questions Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies Acknowledgements  Hong Kong Red Cross  Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies  AABB  WHO/IFRC – • Pre-donation Counselling and Donor Selection (Donor 5.2) • Post-donation Counselling (DP 5.6) • Post-donation Counselling (Donor 5.7) • Blood Donor Selection – Guidelines on Assessing Donor Suitability for Blood Donation • Blood Donor Counselling – Implementation Guidelines

Pages